Ventricular Septal Defect

Congenital MONDO:0002070 Pathograph 30 Show in embeddings browser

A communication between the ventricles, the commonest congenital cardiac malformation and the one most often described as simple. It is not simple, but it is unusual: it is one of the few structural heart lesions whose most likely outcome is that it disappears. In unselected newborns screened by echocardiography, roughly 3.3% have a ventricular septal defect and about nine in ten of those close spontaneously within the first year. What determines the course is the interaction of anatomy, defect size, and the pressure gradient across the defect, and that gradient is not fixed. As pulmonary vascular resistance falls after birth, systemic pressure exceeds pulmonary pressure, so blood shunts left to right, increasing pulmonary flow and volume-loading the left heart. Sustained overcirculation remodels the pulmonary arterioles; pulmonary vascular resistance climbs; the gradient narrows, then equalises, then inverts. Once it has inverted, the same hole that caused the problem has become the pressure-relief valve for a suprasystemic right ventricle, and closing it is contraindicated. The therapeutic window is therefore bounded on both sides - too early risks operating on a defect that would have closed itself, too late converts a correctable lesion into an inoperable one - and the entry is organised so that this reversal, rather than the anatomy, is the spine of the disease.

Ask OpenScientist

Ask a research question about Ventricular Septal Defect. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

2
Inheritance
8
Pathophys.
11
Phenotypes
2
Hypotheses
2
Gaps
30
Pathograph
3
Genes
7
Medical Actions
3
Subtypes
1
Models
12
References
1
Deep Research
👪

Inheritance

2
Sporadic occurrence HP:0003745
The great majority of ventricular septal defects occur sporadically, with no family history and no identified exposure. Recurrence risk counselling rests on this, and on the observation that even monozygotic co-twins are usually discordant.
Sporadic
Show evidence (1 reference)
PMID:3840586 SUPPORT Human Clinical
"Despite identical genes and similar prenatal environments, the concordance rate in identical twins is only about 10%."
Supports predominantly sporadic occurrence: shared genotype does not confer shared phenotype.
Non-Mendelian familial aggregation HP:0001426
A minority of cases aggregate in families. Where a single-gene lesion in the GATA4-NKX2-5-TBX5 septation network is present, transmission can look autosomal dominant, but penetrance is modifier-dependent and the general pattern across families is non-Mendelian. Family history of congenital heart disease is a recognized risk factor that nonetheless explains few cases.
Non-Mendelian inheritance
Show evidence (2 references)
PMID:3840586 SUPPORT Human Clinical
"The several known risk factors for VSD, including a family history of congenital heart disease and exposure to certain drugs, infectious agents, and maternal metabolic disturbances, explain few cases."
Recognizes family history as a risk factor while establishing that it, like the other known factors, accounts for a minority of cases.
PMID:22534315 SUPPORT Model Organism
"The factors that modify rather than cause congenital heart disease substantially affect risk in predisposed individuals."
Supports modifier-dependent penetrance, the reason familial transmission does not follow a clean Mendelian pattern. Evidence source is MODEL_ORGANISM because this is a mouse complex-trait analysis.
◆

Subtypes

3
Muscular (trabecular) ventricular septal defect
A defect bordered entirely by septal muscle. The commonest subtype in unselected newborn screening - 92.6% of defects in one such cohort - and the one that closes spontaneously in the large majority of cases as the muscular septum grows and remodels around it. Closure frequently begins before birth.
Show evidence (2 references)
PMID:31208700 SUPPORT Human Clinical
"The SC rate in those with perimembranous VSD and muscular VSD (mVSD) were 51.4% (18 of 35) and 97.2% (70 of 72), respectively."
Quantifies spontaneous closure for the muscular subtype against the perimembranous comparator.
PMID:38857582 SUPPORT Human Clinical
"Of these, 787 ... were muscular VSDs, 60 ... were perimembranous, and 3 ... were subarterial."
Supports the subtype distribution in an unselected newborn screening cohort.
Perimembranous ventricular septal defect
A defect abutting the fibrous membranous septum. Less common at birth but substantially over-represented among defects that persist, because it closes spontaneously in only roughly half of cases. Within this subtype a diameter of 4 mm or more independently predicts failure to close, which is what makes perimembranous defects the ones that come to intervention.
Show evidence (1 reference)
PMID:31208700 SUPPORT Human Clinical
"perimembranous site and defects ≥4 mm are risk factors for VSD that do not spontaneously close. Independent predictive factors for perimembranous VSD which do not spontaneously close is defects ≥4 mm."
Establishes both the subtype and the within-subtype size threshold as predictors of persistence.
Doubly committed juxta-arterial (subarterial) ventricular septal defect
A defect sitting immediately beneath both arterial valves. Rare - under 1% of screened newborns - and excluded from the spontaneous-closure risk analyses because of small numbers, so its natural history is the least well characterized of the three.
Show evidence (2 references)
PMID:31208700 SUPPORT Human Clinical
"Excluding doubly committed juxta-arterial, perimembranous site and defects ≥4 mm are risk factors for VSD that do not spontaneously close."
Documents that this subtype was excluded from the closure risk-factor analysis, which is why its natural history is stated here as uncharacterized rather than assumed similar.
PMID:38857582 SUPPORT Human Clinical
"Of these, 787 ... were muscular VSDs, 60 ... were perimembranous, and 3 ... were subarterial."
Supports the rarity of the subarterial/juxta-arterial subtype in an unselected newborn screening cohort.
◈

Mechanistic Hypotheses

2
Stochastic morphogenetic error
stochastic_developmental_error ALTERNATIVE
Evidence balance 1 support
Most ventricular septal defects arise as random errors during a complex morphogenetic process, at a rate set by that complexity rather than by any particular genetic or environmental exposure. The prediction is that incidence should be largely invariant across populations and exposures and that monozygotic twins should be substantially discordant - both of which are observed. This remains an epidemiologically supported hypothesis rather than a demonstrated mechanism: somatic mutation, stochastic gene expression, or unmeasured micro-environmental differences could produce the same pattern.
Pathograph links
Stochastic Error in Cardiac Morphogenesis -> Interventricular Communication INDIRECT UNKNOWN INTERMEDIATES A stochastic failure of septal closure during morphogenesis leaves a communication; the intermediates are by hypothesis not systematic.
Show evidence (1 reference)
PMID:3840586 SUPPORT Human Clinical
"Incidence rates are similar in different races and seasons and are unrelated to maternal age, birth order, sex, and socioeconomic status."
The invariance across populations and exposures that this hypothesis predicts.
Cardiac transcription factor network lesion
transcriptional_network_lesion ALTERNATIVE
Evidence balance 2 support
In a minority of cases, and disproportionately in familial ones, the defect results from a specific lesion in the GATA4-NKX2-5-TBX5 septation network. This account explains far fewer cases than the stochastic one but explains them far better, and is the only branch that currently supports mechanistic prediction, family counselling, or modeling. The mouse work makes the relationship between the two accounts explicit: even a defined Nkx2-5 mutation produces a variable phenotype governed by modifier loci, so "genetic cause" and "stochastic variability" are not competing at the level of the individual patient.
Pathograph links
Cardiac Septation Transcriptional Program Disruption -> Interventricular Communication INDIRECT KNOWN INTERMEDIATES Failure of the septation program leaves the interventricular septum incompletely formed.
Show evidence (2 references)
PMID:12845333 SUPPORT Human Clinical
"These results implicate GATA4 as a genetic cause of human cardiac septal defects, perhaps through its interaction with TBX5."
States the network hypothesis in the terms curated here.
PMID:22534315 SUPPORT Model Organism
"The factors that modify rather than cause congenital heart disease substantially affect risk in predisposed individuals."
Supports modifier-dependent penetrance of a defined causal mutation, reconciling the genetic and stochastic accounts. Evidence source is MODEL_ORGANISM because this is a mouse complex-trait analysis.
?

Discussions and Knowledge Gaps

2
How should the intervention window be bounded when the same defect may either close itself or become inoperable?
OPEN QUESTION vsd_intervention_timing_window
Attached to
pathophysiology#Interventricular Communication pathophysiology#Obstructive Pulmonary Vascular Remodeling
The therapeutic window in this disease is bounded on both sides, which is unusual. Operating too early risks intervening on a defect that would have closed spontaneously - the majority outcome, and 83.5% within one year in unselected newborns. Waiting too long allows pulmonary vascular remodeling to become irreversible, converting a correctable lesion into one where closure is contraindicated. Subtype resolves much of this (muscular defects can be watched; large perimembranous defects cannot), but the intermediate case - a moderate perimembranous defect with a growing shunt in an infant who is feeding adequately - is not resolved by the available data, and early age at presentation has been shown specifically not to predict the need for surgery.
Show evidence (1 reference)
PMID:12206559 SUPPORT Human Clinical
"Early age at presentation, in contrast, is not predictive of the need for surgical intervention."
Removes the most intuitive triage variable from consideration, which is what makes the intermediate case genuinely open.
Is the residual, unexplained majority of ventricular septal defects genuinely stochastic, or does it reflect causes not yet detectable?
KNOWLEDGE GAP vsd_stochastic_versus_undiscovered_cause
Attached to
pathophysiology#Stochastic Error in Cardiac Morphogenesis
The stochastic account rests on negative and indirect evidence: flat incidence across exposures, few cases explained by known risk factors, and about 10% monozygotic twin concordance. Twin discordance is the strongest piece, but it does not distinguish true developmental noise from somatic mutation, stochastic gene expression, or micro-environmental differences between co-twins - all of which would be causes, just undetectable ones. The distinction is not academic: a genuinely stochastic process has an irreducible floor, whereas an undetected cause could in principle be prevented. No study has applied somatic variant detection to cardiac tissue from discordant monozygotic twins.
Proposed experiments
Somatic variant analysis of cardiac tissue from monozygotic twins discordant for septal defect
exp_vsd_discordant_twin_somatic_variants
Apply deep somatic variant detection to cardiac tissue or cardiac-lineage-derived cells from monozygotic twin pairs discordant for ventricular septal defect. Recurrent somatic lesions in septation-pathway genes in the affected twin would reclassify part of the "stochastic" residue as a detectable cause; their absence would strengthen the developmental-noise interpretation.
⚙

Pathophysiology

8
Cardiac Septation Transcriptional Program Disruption
Ventricular septation depends on a small network of interacting cardiac transcription factors. GATA4 missense and frameshift mutations segregate with isolated septal defects in large pedigrees; the disease-causing G296S substitution reduces DNA binding and transcriptional activity and abolishes the physical interaction between GATA4 and TBX5. The reciprocal experiment closes the loop: TBX5 missense mutations that cause similar septal defects disrupt the same interaction from the other side. NKX2-5 is the other established locus. What the network explains is a minority of defects, but it explains them mechanistically rather than statistically.
Cardiac transcription factor network lesion
GATA4 hgnc:4173 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves GATA4 (hgnc:4173). hgnc:4173 is a gene from the HUGO Gene Nomenclature Committee. NKX2-5 hgnc:2488 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves NKX2-5 (hgnc:2488). hgnc:2488 is a gene from the HUGO Gene Nomenclature Committee. TBX5 hgnc:11604 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves TBX5 (hgnc:11604). hgnc:11604 is a gene from the HUGO Gene Nomenclature Committee.
ventricular septum development GO:0003281 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal ventricular septum development (GO:0003281). GO:0003281 is a biological process from the Gene Ontology. ⚠ ABNORMAL
interventricular septum UBERON:0002094 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in interventricular septum (UBERON:0002094). UBERON:0002094 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
Nkx2-5(+/-) heterozygous knockout mouse Mus musculus recapitulates A heterozygous null allele of a curated human septation-network gene produces ventricular septal defects in the mouse, which is the mechanism this node asserts.
Downstream
Interventricular Communication Failure of the septation program leaves the interventricular septum incompletely formed. Cardiac transcription factor network lesion
Show evidence (3 references)
PMID:12845333 SUPPORT Human Clinical
"A heterozygous G296S missense mutation of GATA4, a transcription factor essential for heart formation, was found in all available affected family members but not in any control individuals."
Establishes GATA4 as segregating with isolated cardiac septal defects in a linkage pedigree, the causal genetic claim of this node.
PMID:12845333 SUPPORT In Vitro
"the Gata4 mutation abrogated a physical interaction between Gata4 and TBX5, a T-box protein responsible for a subset of syndromic cardiac septal defects. Conversely, interaction of Gata4 and TBX5 was disrupted by specific human TBX5 missense mutations that cause similar cardiac septal defects."
The reciprocal disruption of the GATA4-TBX5 interaction from both sides is what makes this a network mechanism rather than two separate gene associations. Evidence source is IN_VITRO because the interaction was assayed biochemically.
PMID:30834692 SUPPORT Human Clinical
"Significantly higher frequency of different allelle of five variants was observed in cases when compared to the control group, with significant risky effect for the development of septal defect."
Adds common-variant association evidence across NKX2-5, GATA4, and TBX5. Graded PARTIAL because this is a small case-control series reporting genotype frequencies, not a causal assignment.
Stochastic Error in Cardiac Morphogenesis
Most ventricular septal defects have no identifiable genetic or environmental cause, and the epidemiology suggests this is a fact about the disease rather than a gap in ascertainment. Incidence is essentially flat across races, seasons, maternal age, birth order, sex, and socioeconomic status; known risk factors explain few cases; and monozygotic twins, who share genome and prenatal environment, are concordant only about 10% of the time. The inference is that many defects arise as random errors during a morphogenetic process whose complexity sets the error rate - a claim with the practical corollary that many are not preventable.
Stochastic morphogenetic error
ventricular septum development GO:0003281 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal ventricular septum development (GO:0003281). GO:0003281 is a biological process from the Gene Ontology. ⚠ ABNORMAL
interventricular septum UBERON:0002094 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in interventricular septum (UBERON:0002094). UBERON:0002094 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
Nkx2-5(+/-) heterozygous knockout mouse Mus musculus partially recapitulates Same-genotype littermates differ in whether a defect forms, and the variation is attributable to modifier loci and to maternal age rather than to the causal mutation - the experimental analogue of the discordance between monozygotic human twins.
Downstream
Interventricular Communication A stochastic failure of septal closure during morphogenesis leaves a communication; the intermediates are by hypothesis not systematic. Stochastic morphogenetic error
Show evidence (3 references)
PMID:3840586 SUPPORT Human Clinical
"Despite identical genes and similar prenatal environments, the concordance rate in identical twins is only about 10%."
The single most constraining observation for any deterministic account of causation, genetic or environmental.
PMID:3840586 SUPPORT Human Clinical
"The consistency of incidence among individuals with widely differing genes and environments and the frequency of discordance in identical twins suggest that VSDs often occur as random errors in development, at a frequency largely determined by the complexity of normal cardiac morphogenesis."
States the stochastic-error hypothesis this node encodes, with its supporting epidemiological reasoning.
PMID:3840586 SUPPORT Human Clinical
"The several known risk factors for VSD, including a family history of congenital heart disease and exposure to certain drugs, infectious agents, and maternal metabolic disturbances, explain few cases."
Supports the claim that identified causes account for a minority of defects.
Interventricular Communication
The anatomic lesion: a communication between the ventricular chambers. Its location is the single strongest determinant of what happens next. Muscular defects, entirely bordered by septal muscle, close spontaneously in the large majority of cases as the muscular septum grows and remodels around them. Perimembranous defects, which abut the fibrous membranous septum, close far less often. Size matters within subtype - perimembranous defects of 4 mm or more are those that do not close - but subtype dominates.
interventricular septum UBERON:0002094 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in interventricular septum (UBERON:0002094). UBERON:0002094 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Ventricular Septal Defect The deficient septal area is the defining ventricular septal defect phenotype.
Spontaneous Defect Closure Muscular defects in particular are progressively occluded by growth and remodeling of the surrounding septal muscle. This is the majority outcome, not an exception.
Left-to-Right Shunt and Pulmonary Overcirculation A persistent communication permits flow from the higher-pressure left ventricle to the right.
Show evidence (3 references)
PMID:38857582 SUPPORT Human Clinical
"Muscular VSDs showed significantly higher rate of spontaneous closure compared with perimembranous VSDs"
Establishes anatomic subtype as the determinant of outcome, the central claim of this node.
PMID:31208700 SUPPORT Human Clinical
"perimembranous site and defects ≥4 mm are risk factors for VSD that do not spontaneously close. Independent predictive factors for perimembranous VSD which do not spontaneously close is defects ≥4 mm."
Establishes subtype and size as the determinants of persistence, in that order.
PMID:12206559 SUPPORT Human Clinical
"The size and morphology of a ventricular septal defect are important determinants of spontaneous closure and to the need for surgical intervention. Early age at presentation, in contrast, is not predictive of the need for surgical intervention."
Supports morphology and size as determinants, and specifically excludes early presentation as a predictor - a negative finding that matters for management.
Spontaneous Defect Closure
The commonest outcome, and the reason this disease is managed by observation far more often than by intervention. In an unselected newborn cohort 83.5% of all defects had closed by one year, dropping prevalence from 3.3% at birth to 0.5% at age one. The subtype split is stark: muscular defects closed in 86.9% versus 46.9% of perimembranous. Closure begins before birth - a third of fetally diagnosed muscular defects close in utero.
interventricular septum UBERON:0002094 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in interventricular septum (UBERON:0002094). UBERON:0002094 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (3 references)
PMID:38857582 SUPPORT Human Clinical
"After 1 year, 83.5% (607 of 727) of all VSDs had closed spontaneously, resulting in a decrease of prevalence from 3.3% at birth to 0.5% in 1-year old children."
Quantifies spontaneous closure and the resulting fall in prevalence in an unselected screened population.
PMID:31208700 SUPPORT Human Clinical
"The SC rate in those with perimembranous VSD and muscular VSD (mVSD) were 51.4% (18 of 35) and 97.2% (70 of 72), respectively."
Quantifies the subtype-dependent closure rates over seven years of follow-up.
PMID:31928261 SUPPORT Human Clinical
"Spontaneous closure of the VSDs occurred prenatally in 31/64 and 3/11 of fetuses with muscular VSD and perimembranous VSD, respectively."
Documents that closure begins in utero, which is why fetally detected defects cannot be counted as future disease.
Left-to-Right Shunt and Pulmonary Overcirculation
Because systemic vascular resistance normally far exceeds pulmonary, blood crosses the defect from left to right, recirculating through the lungs. The magnitude of the shunt is set by the ratio of the two resistances together with defect size, not by defect size alone - which is why the shunt is small in the first days of life while pulmonary resistance is still high, and grows over the following weeks as it falls. The consequence is excess pulmonary blood flow and pressure, and a volume load returning to the left atrium and ventricle.
pulmonary artery UBERON:0002012 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in pulmonary artery (UBERON:0002012). UBERON:0002012 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Left Ventricular Volume Overload and Heart Failure Recirculated pulmonary blood returns to the left heart as a volume load.
Obstructive Pulmonary Vascular Remodeling Chronic exposure of the pulmonary vascular bed to increased flow and pressure drives remodeling of the small pulmonary arteries.
Failure to Thrive Increased pulmonary flow raises the work of breathing and reduces systemic flow, increasing caloric needs while impairing feeding and growth.
Tachypnea Pulmonary arterial engorgement, pulmonary edema, and airway compression reduce lung compliance and produce rapid breathing.
Cardiomegaly A significant shunt produces chamber enlargement visible as cardiomegaly.
Heart Murmur Turbulent flow through the defect produces the characteristic murmur.
Show evidence (1 reference)
PMID:39711769 SUPPORT Other
"uncorrected left-to-right (L-R) intracardiac shunt leading to overload of the pulmonary circulation and a progressive increase of PVR"
States the shunt-to-overcirculation-to-rising-resistance sequence this node begins. Evidence source is OTHER because this is a review.
Left Ventricular Volume Overload and Heart Failure
The left ventricle handles the recirculating volume by dilating, and in a large defect this presents in infancy as congestive heart failure - tachypnoea, sweating with feeds, poor weight gain - typically after the first few weeks, once falling pulmonary resistance has allowed the shunt to grow. Failure to thrive in this setting is a haemodynamic sign rather than a nutritional one.
heart left ventricle UBERON:0002084 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in heart left ventricle (UBERON:0002084). UBERON:0002084 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Congestive Heart Failure Volume loading of the left ventricle beyond its compensatory capacity manifests as congestive heart failure in infancy.
Show evidence (2 references)
PMID:39711769 SUPPORT Other
"A congenital L-R shunt, when significant, can cause volume loading of the right or left ventricle, with short and long-term implications in terms of arrhythmia, heart failure, exercise intolerance etc."
Links a significant congenital left-to-right shunt to ventricular volume loading and heart failure, the claim of this node. Evidence source is OTHER because this is a review.
PMID:25523232 SUPPORT Other
"the symptoms typically become ... between the ages of 4 and 8 weeks ... Retardation of growth is a major ... The increase in the work of breathing ... results in the need for increased caloric ... which cannot be met during infancy."
Supports the delayed infant presentation and growth consequences of a hemodynamically significant defect. Evidence source is OTHER because this is a review.
Obstructive Pulmonary Vascular Remodeling
Longstanding exposure to increased pulmonary flow and pressure remodels the pulmonary vascular bed. Endothelial injury and the module-conserved smooth muscle response progressively narrow the small pulmonary vessels and raise pulmonary vascular resistance. This node conforms to the conserved central effector of the `pulmonary_vascular_remodeling` module, substituting shunt overcirculation for the BMPR2 lesion or acquired endothelial injury that trigger it in other forms of pulmonary arterial hypertension. It is the point of no return: the remodeling is what makes the disease irreversible, and once it is severe the haemodynamics that follow cannot be undone by closing the defect.
pulmonary artery smooth muscle cell CL:0000192 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves pulmonary artery smooth muscle cell, annotated with smooth muscle cell (CL:0000192). CL:0000192 is a cell type from the Cell Ontology. pulmonary artery endothelial cell CL:0000115 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves pulmonary artery endothelial cell, annotated with endothelial cell (CL:0000115). CL:0000115 is a cell type from the Cell Ontology.
blood vessel remodeling GO:0001974 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated blood vessel remodeling (GO:0001974). GO:0001974 is a biological process from the Gene Ontology. ↕ DYSREGULATED
pulmonary artery UBERON:0002012 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in pulmonary artery (UBERON:0002012). UBERON:0002012 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Shunt Reversal and Eisenmenger Syndrome Rising pulmonary vascular resistance progressively narrows, then reverses, the interventricular pressure gradient.
Pulmonary Arterial Hypertension Progressive vascular remodeling raises pulmonary vascular resistance and hence pulmonary arterial pressure.
Show evidence (2 references)
PMID:39711769 SUPPORT Other
"the longstanding exposure of the pulmonary vascular bed to increased flow and pressure can result in vascular remodelling and progressive increase in pulmonary vascular resistance (PVR)"
Directly links shunt overcirculation to pulmonary vascular remodeling and rising resistance, the mechanism this conforming node instantiates. Evidence source is OTHER because this is a review.
PMID:25523232 SUPPORT Other
"the increase in ... blood flow, and raised ... pressures, will produce endothelial damage, and permanent changes in ... resistance."
Directly supports endothelial injury and persistent resistance change in the shunt-exposed pulmonary vascular bed. Evidence source is OTHER because this is a review.
Shunt Reversal and Eisenmenger Syndrome
When pulmonary vascular resistance rises to severe levels behind a large unrepaired post-tricuspid shunt, the direction of flow becomes bidirectional and then right to left. Deoxygenated blood enters the systemic circulation, producing cyanosis, secondary erythrocytosis, and multiorgan involvement. The clinically decisive point is that the defect has changed role: it is now the escape route for a suprasystemic right ventricle, and closing it is contraindicated rather than merely futile.
interventricular septum UBERON:0002094 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in interventricular septum (UBERON:0002094). UBERON:0002094 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Cyanosis Right-to-left flow delivers deoxygenated blood into the systemic circulation.
Polycythemia Chronic hypoxaemia drives a compensatory secondary erythrocytosis.
Show evidence (3 references)
PMID:39711769 SUPPORT Other
"Eisenmenger syndrome, appearing when a large post-tricuspid shunt is left uncorrected and pulmonary vascular disease (PVD) is severe, so the shunt becomes bidirectional or right-to-left, causing cyanosis"
Defines the syndrome and the shunt reversal that constitutes it. Evidence source is OTHER because this is a review.
PMID:39711769 SUPPORT Other
"Closing the defects is contraindicated"
The reversal of therapeutic logic this node turns on, stated in the guideline-derived classification of Eisenmenger syndrome. Evidence source is OTHER because this is a review.
PMID:39711769 SUPPORT Other
"experts believe that the right ventricle of many Eisenmenger patients is optimally adapted to the increased afterload and is "unloaded" by R-L shunting though the unrepaired defect, supporting cardiac output at the expense of cyanosis."
Supports the role of the reversed shunt as a right-ventricular pressure relief route. Evidence source is OTHER because this is a review.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Ventricular Septal Defect Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

11
Blood 1
Polycythemia HP:0001901 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Polycythemia (HP:0001901). HP:0001901 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39711769 SUPPORT Other
"Chronic cyanosis is associated with haematological changes, such as secondary erythrocytosis, thrombocytopenia, predisposition to bleeding and thrombosis"
Documents secondary erythrocytosis as a consequence of chronic cyanosis, alongside the paradoxical bleeding-and-thrombosis phenotype. Evidence source is OTHER because this is a review.
Cardiovascular 4
Ventricular Septal Defect OBLIGATE HP:0001629 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ventricular septal defect (HP:0001629). HP:0001629 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38857582 SUPPORT Human Clinical
"The prevalence of VSDs in unselected newborns was 3.3%."
Establishes the defect in an unselected screened newborn population.
Congestive Heart Failure HP:0001635 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Congestive heart failure (HP:0001635). HP:0001635 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39711769 SUPPORT Other
"A congenital L-R shunt, when significant, can cause volume loading of the right or left ventricle, with short and long-term implications in terms of arrhythmia, heart failure, exercise intolerance etc."
Attributes heart failure to shunt-driven ventricular volume loading. Evidence source is OTHER because this is a review.
Pulmonary Arterial Hypertension HP:0002092 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pulmonary arterial hypertension (HP:0002092), qualified as course progressive. HP:0002092 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (1 reference)
PMID:39711769 SUPPORT Other
"Pulmonary arterial hypertension (PAH) is defined as increase in mean pulmonary arterial pressure and pulmonary vascular resistance (PVR). It can be associated with congenital heart disease (CHD)"
Establishes pulmonary arterial hypertension as a recognized congenital heart disease association. Evidence source is OTHER because this is a review.
Cardiomegaly HP:0001640 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cardiomegaly (HP:0001640). HP:0001640 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25523232 SUPPORT Other
"Cardiomegaly is the rule in such instances."
Directly supports cardiomegaly in hemodynamically significant ventricular septal defect. Evidence source is OTHER because this is a review.
Digestive 1
Hepatomegaly HP:0002240 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hepatomegaly (HP:0002240). HP:0002240 is a phenotype from the Human Phenotype Ontology.
Retained as an established bedside manifestation of infant heart failure, but intentionally left without an evidence block or graph edge because no cached source in this entry documents hepatomegaly specifically in ventricular septal defect.
Immune 1
Recurrent Respiratory Infections HP:0002205 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Recurrent respiratory infections (HP:0002205). HP:0002205 is a phenotype from the Human Phenotype Ontology.
Retained for clinical completeness but intentionally left without an evidence block or graph edge because no cached source in this entry documents recurrent respiratory infection specifically in ventricular septal defect.
Integument 1
Cyanosis HP:0000961 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cyanosis (HP:0000961). HP:0000961 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39711769 SUPPORT Other
"Chronic hypoxaemia manifests as cyanosis, which can be mild or severe and is more evident on physical activity."
Attributes cyanosis to chronic hypoxaemia following shunt reversal and notes its exertional accentuation. Evidence source is OTHER because this is a review.
Respiratory 1
Tachypnea HP:0002789 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Tachypnea (HP:0002789). HP:0002789 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25523232 SUPPORT Other
"The engorgement of the pulmonary arterial circulation may cause pulmonary oedema ... results in lower airway disease, and produces the symptoms of wheezing, tachypnea"
Directly supports tachypnea from pulmonary overcirculation in ventricular septal defect. Evidence source is OTHER because this is a review.
Growth 1
Failure to Thrive HP:0001508 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Failure to thrive (HP:0001508). HP:0001508 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25523232 SUPPORT Other
"Retardation of growth is a major ... The increase in the work of breathing ... results in the need for increased caloric ... which cannot be met during infancy."
Directly supports impaired growth from pulmonary overcirculation and increased work of breathing in ventricular septal defect. Evidence source is OTHER because this is a review.
Other 1
Heart Murmur HP:0030148 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Heart murmur (HP:0030148). HP:0030148 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25523232 SUPPORT Other
"the murmur is harsh and holosystolic."
Supports a characteristic murmur specifically in ventricular septal defect. Evidence source is OTHER because this is a review.
🧬

Genetic Associations

3
GATA4
Gene: GATA4 hgnc:4173 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is GATA4 (hgnc:4173). hgnc:4173 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (1 reference)
PMID:12845333 SUPPORT Human Clinical
"In a second family, we identified a frame-shift mutation of GATA4 (E359del) that was transcriptionally inactive and segregated with cardiac septal defects."
Independent segregating mutation in a second pedigree, which is what raises this from association to causation.
NKX2-5
Gene: NKX2-5 hgnc:2488 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is NKX2-5 (hgnc:2488). hgnc:2488 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (1 reference)
PMID:12845333 SUPPORT Human Clinical
"Only one causative gene, NKX2-5, has been identified through genetic linkage analysis of pedigrees with non-syndromic CHDs."
Establishes NKX2-5 as a linkage-identified causative gene for non-syndromic congenital heart defects.
TBX5
Gene: TBX5 hgnc:11604 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is TBX5 (hgnc:11604). hgnc:11604 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (1 reference)
PMID:12845333 SUPPORT In Vitro
"interaction of Gata4 and TBX5 was disrupted by specific human TBX5 missense mutations that cause similar cardiac septal defects."
Establishes that disease-causing TBX5 mutations converge on the same protein-protein interaction. Evidence source is IN_VITRO because the interaction was assayed biochemically.
💊

Medical Actions

7
Surgical Ventricular Septal Defect Closure
Action: surgical procedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is surgical procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Patch closure of the defect on cardiopulmonary bypass. Indicated for a large defect with heart failure or significant pulmonary overcirculation, and timed to precede irreversible pulmonary vascular disease. Contraindicated once Eisenmenger physiology is established.
Mechanism Target:
INHIBITS Left-to-Right Shunt and Pulmonary Overcirculation — Closing the communication abolishes the shunt and the pulmonary overcirculation that drives vascular remodeling.
Show evidence (3 references)
PMID:25523232 SUPPORT Other
"Surgical closure of large and non-restrictive defects ... in the setting of failure to thrive and symptoms of excessive pulmonary blood flow. ... the recommendation is usually to close these defects before the infant reaches one year of age."
Supports closure of symptomatic large defects before pulmonary vascular disease develops. Evidence source is OTHER because this is a review.
PMID:12206559 SUPPORT Human Clinical
"Surgical closure was required in 41 (14%) cases, and 155 (54%) defects closed spontaneously."
Places surgical closure in proportion against spontaneous closure in a followed cohort of isolated defects.
PMID:39711769 REFUTE Other
"Closing the defects is contraindicated"
Refutes closure specifically in the Eisenmenger subgroup, where the defect has become the pressure-relief route for a suprasystemic right ventricle. Evidence source is OTHER because this is a review carrying the guideline-derived classification.
Transcatheter Device Closure
Action: transcatheter device closureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is transcatheter device closure, annotated with Therapeutic Procedure (NCIT:C49236). NCIT:C49236 is a clinical intervention from the NCI Thesaurus. Ontology label: Therapeutic Procedure NCIT:C49236
Catheter-delivered occluder device closure, avoiding sternotomy and bypass in anatomically suitable defects.
Mechanism Target:
INHIBITS Left-to-Right Shunt and Pulmonary Overcirculation — Device occlusion abolishes the interventricular communication and its shunt.
Show evidence (2 references)
PMID:25523232 SUPPORT Other
"both muscular and perimembranous defects can be closed percutaneously by insertion of devices using cardiac catheterisation"
Directly supports percutaneous device closure for anatomically suitable muscular and perimembranous defects. Evidence source is OTHER because this is a review.
PMID:31208700 SUPPORT Human Clinical
"During the 7-year follow-up period, 18 cases required surgical or transcatheter closure."
Documents transcatheter closure alongside surgery as the intervention used in the minority of defects that do not close spontaneously.
Targeted Pulmonary Arterial Hypertension Therapy
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: bosentan CHEBI:51450 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses bosentan (CHEBI:51450). CHEBI:51450 is a therapeutic agent from Chemical Entities of Biological Interest. sildenafil CHEBI:9139 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses sildenafil (CHEBI:9139). CHEBI:9139 is a therapeutic agent from Chemical Entities of Biological Interest.
Pulmonary vasodilator therapy, used both to treat established pulmonary arterial hypertension and, in a "treat and repair" strategy, to lower pulmonary vascular resistance far enough to bring a borderline patient back within operability criteria.
Mechanism Target:
MODULATES Obstructive Pulmonary Vascular Remodeling — Pulmonary vasodilator therapy lowers the functional component of pulmonary vascular resistance; it does not imply reversal of fixed structural remodeling.
Show evidence (3 references)
PMID:39711769 SUPPORT Other
"Others may benefit from a "treat and repair" strategy, which involves the use of PAH therapy to achieve a drop in PVR, with the aim of achieving operability criteria."
Supports the treat-and-repair rationale. Graded PARTIAL because the source states it as a strategy some patients may benefit from, not as an established indication with demonstrated outcomes. Evidence source is OTHER because this is a review.
PMID:39711769 SUPPORT Other
"There is now evidence to support a sustained, long-term beneficial effect of bosentan in Eisenmenger patients"
Names the endothelin receptor antagonist curated as a therapeutic agent and supports a sustained effect in the Eisenmenger subgroup - the same patients in whom defect closure is contraindicated, which is what makes medical therapy the only option there.
PMID:39711769 SUPPORT Other
"the phosphodiesterase type 5 inhibitors (PDE-5i), sildenafil and tadalafil, have also shown favourable functional and haemodynamic effects in Eisenmenger patients."
Names the phosphodiesterase-5 inhibitor curated as a therapeutic agent. Graded PARTIAL because the source itself describes these as "less robust studies" than the bosentan evidence.
Palliative Pulmonary Artery Banding
Action: surgical procedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is surgical procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Rare palliative narrowing of the pulmonary trunk to reduce pulmonary flow when definitive closure is not immediately feasible, particularly for difficult large muscular or multiple defects.
Mechanism Target:
INHIBITS Left-to-Right Shunt and Pulmonary Overcirculation — Banding increases pulmonary outflow resistance and reduces pulmonary overcirculation without closing the defect.
Show evidence (1 reference)
PMID:25523232 SUPPORT Other
"Only in rare cases is palliative banding of the pulmonary trunk now recommended."
Supports pulmonary artery banding as a rare palliative intervention. Evidence source is OTHER because this is a review.
ACE-Inhibitor Afterload Reduction
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: ACE inhibitor NCIT:C247 NCI Thesaurus (NCIT) Relation: this treatment uses this therapeutic agent This treatment uses ACE inhibitor (NCIT:C247). NCIT:C247 is a therapeutic agent from the NCI Thesaurus.
Angiotensin-converting-enzyme inhibition can reduce afterload and favor forward systemic output, thereby reducing left-to-right shunt volume in a symptomatic infant awaiting closure.
Mechanism Target:
MODULATES Left-to-Right Shunt and Pulmonary Overcirculation — Systemic afterload reduction favors forward flow and reduces the shunt fraction without closing the communication.
Show evidence (1 reference)
PMID:25523232 SUPPORT Other
"Afterload reduction is achieved using inhibi...tors of angiotensin converting enzyme."
Directly supports ACE-inhibitor afterload reduction. Evidence source is OTHER because this is a review.
🌍

Environmental Factors

2
Periconceptional folic acid supplementation
periconceptional folic acid supplementation exposure ECTO:9000123 Environmental Conditions, Treatments and Exposures Ontology (ECTO) Relation: this environmental factor is this exposure This environmental factor is increased periconceptional folic acid supplementation exposure, annotated with exposure to folic acid (ECTO:9000123). ECTO:9000123 is an exposure from the Environmental Conditions, Treatments and Exposures Ontology.
Maternal periconceptional folic acid supplement use is associated with an approximately 20% lower prevalence of congenital heart defects. It acts, if it acts causally, during the same organogenetic window in which septation occurs - which is what makes it a candidate modifier of the error rate the stochastic account posits, rather than a treatment of an established defect.
Show evidence (1 reference)
PMID:19952004 SUPPORT Human Clinical
"Our results support the hypothesis that additional periconceptional folic acid use reduces CHD risk in infants."
Supports a protective association. Graded PARTIAL because the finding is for congenital heart defects as a class in a registry-based case-control design, not ventricular septal defect specifically.
Mechanism Target:
PROTECTS_AGAINST Stochastic Error in Cardiac Morphogenesis — Adequate periconceptional folate is proposed to lower the rate of morphogenetic error during septation. The intermediates are unknown and the association is measured at the level of congenital heart defects as a class, so the edge is deliberately typed as indirect with unknown intermediates.
Show evidence (1 reference)
PMID:19952004 SUPPORT Human Clinical
"Use of periconceptional folic acid supplements was related to approximately 20% reduction in the prevalence of any CHD."
Quantifies the protective association. Graded PARTIAL because it is measured across all congenital heart defects rather than ventricular septal defect specifically, and because no mechanism linking folate to septation error is demonstrated.
Maternal diabetes mellitus in pregnancy
Offspring of women with diabetes carry an increased risk of ventricular septal defect. The effect is defect-specific and quantified: a relative risk of 1.31 for ventricular septal defect in offspring of women with gestational diabetes. Pre-gestational diabetes carries a higher overall risk of congenital heart defects than gestational diabetes does, which is mechanistically coherent - septation occurs in weeks three to eight, before gestational hyperglycaemia typically develops - and is one of the few places where exposure timing and developmental timing can be compared directly.
Show evidence (1 reference)
PMID:35104296 SUPPORT Human Clinical
"The RRs of overall CAs and CHDs in offspring of women with PGDM were higher than those in offspring of women with GDM."
Establishes the pre-gestational versus gestational gradient, the observation that lets exposure timing be compared against the organogenetic window.
Mechanism Target:
PREDISPOSES Stochastic Error in Cardiac Morphogenesis — A diabetic intrauterine environment during organogenesis raises the probability of a septation error. Typed as predisposing rather than triggering because the great majority of exposed pregnancies produce no defect.
Show evidence (1 reference)
PMID:35104296 SUPPORT Human Clinical
"ventricular septal defect (RR = 1.31, 95% CI 1.24 to 1.38, I2 = 0%, P = 0.960)"
A defect-specific relative risk with no heterogeneity across the pooled population-based studies, which is what makes this stronger than the class-level associations elsewhere in this section.
🔬

Diagnosis

3
Transthoracic Echocardiography
Echocardiography is the diagnostic modality for ventricular septal defect and is what defines its modern population epidemiology: the principal birth and one-year prevalence estimates cited in this entry come from a cohort in which unselected newborns underwent echocardiography rather than being referred on clinical suspicion. This matters because clinical ascertainment misses many small muscular defects that subsequently close.
echocardiography NCIT:C16525 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:31208700 SUPPORT Human Clinical
"We conducted a prospective study at 3 hospitals, all newborns underwent echocardiography."
Establishes universal newborn echocardiography as the ascertainment method behind the occurrence figures curated here.
Fetal Echocardiography
Prenatal detection by fetal echocardiography, the setting in which in-utero spontaneous closure is observed. Because a third of fetally diagnosed muscular defects close before birth, a prenatal diagnosis cannot be counted as a postnatal case.
echocardiography NCIT:C16525 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:31928261 SUPPORT Human Clinical
"Spontaneous closure of the VSDs occurred prenatally in 31/64 and 3/11 of fetuses with muscular VSD and perimembranous VSD, respectively."
Documents prenatal detection and in-utero closure in a fetally ascertained cohort.
Cardiac Catheterization
The measurement that decides operability. Echocardiography establishes the defect; catheterization quantifies pulmonary vascular resistance and the pulmonary-to-systemic flow ratio, and permits the pulmonary circulation to be challenged pharmacologically or the defect temporarily occluded before a decision is made. This entry's whole Eisenmenger and treat-and-repair reasoning depends on those numbers, so the diagnostic modality that produces them belongs here rather than being implied.
cardiac catheterization NCIT:C38044 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:39711769 SUPPORT Other
"Cardiac catheterization is at the center of the evaluation and follow-up of these patients, collecting "baseline" data and providing the opportunity to challenge the pulmonary circulation, manipulate the loading status, or temporarily occlude the defect."
States the central role of catheterization in the evaluation on which operability is judged. Evidence source is OTHER because this is a review.
📊

Prevalence

3
Unselected newborns screened by echocardiography
Birth Prevalence 3300.0 per 100,000 >1 in 1,000
3.3% of 25,556 newborns in a universal screening cohort.
Show evidence (1 reference)
PMID:38857582 SUPPORT Human Clinical
"The prevalence of VSDs in unselected newborns was 3.3%."
Birth prevalence from universal newborn echocardiographic screening.
One-year-old children, same screening cohort
Point Prevalence 500.0 per 100,000 >1 in 1,000
0.5% at age one after spontaneous closure. Recorded separately from the birth figure because the two are not comparable: most of the difference is closure, not ascertainment.
Show evidence (1 reference)
PMID:38857582 SUPPORT Human Clinical
"ultimately resulting in a prevalence of VSD in 1-year-old children of 0.5%."
Point prevalence at one year in the same cohort.
Chinese newborns screened by echocardiography
Birth Prevalence 1674.0 per 100,000 >1 in 1,000
113 of 6,750 screened newborns (16.74 per 1,000); rounded to 1,674 per 100,000.
Show evidence (1 reference)
PMID:31208700 SUPPORT Human Clinical
"In 6,750 newborns, VSDs were detected in 113 cases"
Supplies the numerator and denominator for the birth-prevalence estimate.
🌍

Epidemiology

2
Prevalence in unselected newborns and fall after spontaneous closure
Screening echocardiography in unselected newborns finds a ventricular septal defect in about 3.3%, falling to 0.5% by age one as most close spontaneously.
Show evidence (2 references)
PMID:38857582 SUPPORT Human Clinical
"The prevalence of VSDs in unselected newborns was 3.3%."
Birth prevalence from universal newborn echocardiographic screening.
PMID:38857582 SUPPORT Human Clinical
"ultimately resulting in a prevalence of VSD in 1-year-old children of 0.5%."
The one-year prevalence after spontaneous closure, which is what makes birth-prevalence and childhood-prevalence figures non-comparable.
Share of congenital heart disease in newborn screening
Ventricular septal defects accounted for 62.8% of congenital heart disease detected by universal newborn echocardiographic screening.
Show evidence (1 reference)
PMID:31208700 SUPPORT Human Clinical
"accounting for 62.8% of congenital heart disease"
Quantifies the share of congenital heart disease attributable to ventricular septal defect in a screened newborn population.
🐁

Animal Models

1
Nkx2-5(+/-) heterozygous knockout mouse Genetic model with mapped modifier loci
The model that makes this entry's two hypotheses compatible rather than competing. Phenotyping over 3,100 hearts from an intercross of two inbred backgrounds carrying the same heterozygous Nkx2-5 knockout mapped modifier loci on chromosomes 6, 8, and 10 governing susceptibility to membranous defects, with the chromosome 6 locus overlapping one for muscular defect susceptibility. A defined causal mutation therefore does not determine whether a defect forms - genetic background does much of the work. The maternal-age finding is the sharper result: maternal age correlated with defect risk in Nkx2-5(+/-) animals but not in wild-type littermates, unrelated to aneuploidy, meaning an environmental variable acts only on a genetically predisposed background.
Species
Mus musculus
Genotype
Nkx2-5(+/-) heterozygous knockout on a C57BL/6 x FVB/N second-generation intercross
Publication
PMID:22534315
Pathograph links
Cardiac Septation Transcriptional Program Disruption recapitulates fidelity: high A heterozygous null allele of a curated human septation-network gene produces ventricular septal defects in the mouse, which is the mechanism this node asserts.
Stochastic Error in Cardiac Morphogenesis partially recapitulates fidelity: moderate Same-genotype littermates differ in whether a defect forms, and the variation is attributable to modifier loci and to maternal age rather than to the causal mutation - the experimental analogue of the discordance between monozygotic human twins.
Limitations: The model shows that the residual variance has structure - mapped modifier loci and a maternal-age effect - which is not the same claim as irreducible developmental noise. It demonstrates that defect occurrence is incompletely determined by genotype; it does not establish that the human residual is stochastic rather than merely undetected.
Show evidence (3 references)
PMID:22534315 SUPPORT Model Organism
"Genetic linkage analysis mapped loci with lod scores of 5 to 7 on chromosomes 6, 8, and 10 that influence the susceptibility to membranous VSDs in Nkx2-5(+/-) animals."
Establishes mapped modifier loci acting on a defined causal mutation. Evidence source is MODEL_ORGANISM because this is a mouse intercross.
PMID:22534315 SUPPORT Model Organism
"Multiple logistic regression analysis for environmental variables revealed that maternal age is correlated with the risk of membranous and muscular VSD in Nkx2-5(+/-) but not wild-type animals."
The genotype-conditional environmental effect: maternal age acts only on the predisposed background, which is exactly the gene-environment structure the two curated hypotheses jointly predict.
PMID:22534315 SUPPORT Model Organism
"The risk of a VSD is not only complex but dynamic. Whereas the effect of genetic modifiers on risk remains constant, the effect of maternal aging increases over time."
Distinguishes a constant genetic contribution from a time-varying environmental one, which is why neither hypothesis in this entry is framed as sufficient on its own.
{ }

Source YAML

click to show 
name: Ventricular Septal Defect
creation_date: "2026-08-10T13:40:00Z"
category: Congenital
disease_term:
  preferred_term: ventricular septal defect
  term:
    id: MONDO:0002070
    label: ventricular septal defect
description: >
  A communication between the ventricles, the commonest congenital cardiac
  malformation and the one most often described as simple. It is not simple, but
  it is unusual: it is one of the few structural heart lesions whose most likely
  outcome is that it disappears. In unselected newborns screened by
  echocardiography, roughly 3.3% have a ventricular septal defect and about
  nine in ten of those close spontaneously within the first year.
  What determines the course is the interaction of anatomy, defect size, and the
  pressure gradient across the defect, and that gradient is not fixed. As
  pulmonary vascular resistance falls after birth, systemic pressure exceeds
  pulmonary pressure, so blood shunts left to right, increasing pulmonary flow
  and volume-loading the left heart. Sustained overcirculation remodels the
  pulmonary arterioles; pulmonary vascular resistance climbs; the gradient
  narrows, then equalises, then inverts. Once it has inverted, the same hole
  that caused the problem has become the pressure-relief valve for a
  suprasystemic right ventricle, and closing it is contraindicated. The
  therapeutic window is therefore bounded on both sides - too early risks
  operating on a defect that would have closed itself, too late converts a
  correctable lesion into an inoperable one - and the entry is organised so that
  this reversal, rather than the anatomy, is the spine of the disease.
synonyms:
- VSD
- interventricular septal defect
has_subtypes:
- name: Muscular
  display_name: Muscular (trabecular) ventricular septal defect
  description: >
    A defect bordered entirely by septal muscle. The commonest subtype in
    unselected newborn screening - 92.6% of defects in one such cohort - and the
    one that closes spontaneously in the large majority of cases as the muscular
    septum grows and remodels around it. Closure frequently begins before birth.
  evidence:
  - reference: PMID:31208700
    reference_title: "Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The SC rate in those with perimembranous VSD and muscular VSD (mVSD) were
      51.4% (18 of 35) and 97.2% (70 of 72), respectively.
    explanation: >-
      Quantifies spontaneous closure for the muscular subtype against the
      perimembranous comparator.
  - reference: PMID:38857582
    reference_title: "The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Of these, 787 ... were muscular VSDs, 60 ... were perimembranous, and 3 ...
      were subarterial.
    explanation: >-
      Supports the subtype distribution in an unselected newborn screening
      cohort.
- name: Perimembranous
  display_name: Perimembranous ventricular septal defect
  description: >
    A defect abutting the fibrous membranous septum. Less common at birth but
    substantially over-represented among defects that persist, because it closes
    spontaneously in only roughly half of cases. Within this subtype a diameter
    of 4 mm or more independently predicts failure to close, which is what makes
    perimembranous defects the ones that come to intervention.
  evidence:
  - reference: PMID:31208700
    reference_title: "Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      perimembranous site and defects ≥4 mm are risk factors for VSD that do not
      spontaneously close. Independent predictive factors for perimembranous VSD
      which do not spontaneously close is defects ≥4 mm.
    explanation: >-
      Establishes both the subtype and the within-subtype size threshold as
      predictors of persistence.
- name: Doubly Committed Juxta-arterial
  display_name: Doubly committed juxta-arterial (subarterial) ventricular septal defect
  description: >
    A defect sitting immediately beneath both arterial valves. Rare - under 1% of
    screened newborns - and excluded from the spontaneous-closure risk analyses
    because of small numbers, so its natural history is the least well
    characterized of the three.
  evidence:
  - reference: PMID:31208700
    reference_title: "Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Excluding doubly committed juxta-arterial, perimembranous site and defects
      ≥4 mm are risk factors for VSD that do not spontaneously close.
    explanation: >-
      Documents that this subtype was excluded from the closure risk-factor
      analysis, which is why its natural history is stated here as
      uncharacterized rather than assumed similar.
  - reference: PMID:38857582
    reference_title: "The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Of these, 787 ... were muscular VSDs, 60 ... were perimembranous, and 3 ...
      were subarterial.
    explanation: >-
      Supports the rarity of the subarterial/juxta-arterial subtype in an
      unselected newborn screening cohort.
notes: >
  Two mutually exclusive downstream branches hang off the same anatomic node, and
  both are curated: spontaneous closure and progressive pulmonary vascular
  disease. Modeling only the second would misrepresent the disease, since
  closure is the majority outcome. Anatomic subtype is what separates them -
  muscular defects close spontaneously in 87-97% of series, perimembranous in
  roughly 47-51% - so subtype is curated as `has_subtypes` entries with their own
  evidence, and the subtype-stratified occurrence figures are carried on
  `prevalence` records rather than left in prose.

  Failure to thrive, tachypnea, and cardiomegaly are supported by a
  ventricular-septal-defect-specific clinical review. The graph attaches them to
  the significant-shunt branch at the level supported by that source rather than
  manufacturing more specific chamber-level arrows.

  `conforms_to` is declared for the pulmonary vascular arm only
  (`pulmonary_vascular_remodeling#Obstructive Pulmonary Vascular Remodeling`),
  and deliberately not for the shunt or Eisenmenger nodes. The module's
  conserved central effector is the remodeled small pulmonary artery, which this
  disorder genuinely instantiates with an overcirculation trigger substituted for
  BMPR2 loss or acquired endothelial injury. Shunt reversal is a haemodynamic
  consequence downstream of that remodeling, not another instance of it.

  The stochastic-error trigger node is not a placeholder for ignorance. The
  monozygotic twin concordance for ventricular septal defect is about 10%, which
  constrains any purely genetic or purely environmental account far more sharply
  than the absence of an identified cause would on its own. It is curated as a
  node with its own evidence because it makes a testable claim.

  The NKX2-5, GATA4, and TBX5 association study (PMID:30834692) reports
  polymorphism frequencies in a small Egyptian case-control series and is graded
  PARTIAL wherever cited; it is not treated as establishing causation, unlike the
  GATA4 linkage pedigrees.

  Several passages in the PMID:39711769 cache carry whitespace artifacts from
  text extraction ("multiple organinvolvement", "present.Closing"). Snippets
  quote around these rather than reproducing the corruption, which is why some
  quotations from that source are shorter than the sentence they come from.
pathophysiology:
- name: Cardiac Septation Transcriptional Program Disruption
  biological_scale: MOLECULAR
  role: trigger
  description: >
    Ventricular septation depends on a small network of interacting cardiac
    transcription factors. GATA4 missense and frameshift mutations segregate with
    isolated septal defects in large pedigrees; the disease-causing G296S
    substitution reduces DNA binding and transcriptional activity and abolishes
    the physical interaction between GATA4 and TBX5. The reciprocal experiment
    closes the loop: TBX5 missense mutations that cause similar septal defects
    disrupt the same interaction from the other side. NKX2-5 is the other
    established locus. What the network explains is a minority of defects, but it
    explains them mechanistically rather than statistically.
  locations:
  - preferred_term: interventricular septum
    term:
      id: UBERON:0002094
      label: interventricular septum
  biological_processes:
  - preferred_term: ventricular septum development
    term:
      id: GO:0003281
      label: ventricular septum development
    modifier: ABNORMAL
  genes:
  - preferred_term: GATA4
    term:
      id: hgnc:4173
      label: GATA4
  - preferred_term: NKX2-5
    term:
      id: hgnc:2488
      label: NKX2-5
  - preferred_term: TBX5
    term:
      id: hgnc:11604
      label: TBX5
  evidence:
  - reference: PMID:12845333
    reference_title: "GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A heterozygous G296S missense mutation of GATA4, a transcription factor
      essential for heart formation, was found in all available affected family
      members but not in any control individuals.
    explanation: >-
      Establishes GATA4 as segregating with isolated cardiac septal defects in a
      linkage pedigree, the causal genetic claim of this node.
  - reference: PMID:12845333
    reference_title: "GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      the Gata4 mutation abrogated a physical interaction between Gata4 and TBX5,
      a T-box protein responsible for a subset of syndromic cardiac septal
      defects. Conversely, interaction of Gata4 and TBX5 was disrupted by
      specific human TBX5 missense mutations that cause similar cardiac septal
      defects.
    explanation: >-
      The reciprocal disruption of the GATA4-TBX5 interaction from both sides is
      what makes this a network mechanism rather than two separate gene
      associations. Evidence source is IN_VITRO because the interaction was
      assayed biochemically.
  - reference: PMID:30834692
    reference_title: "Association of NKX2-5, GATA4, and TBX5 polymorphisms with congenital heart disease in Egyptian children."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Significantly higher frequency of different allelle of five variants was
      observed in cases when compared to the control group, with significant
      risky effect for the development of septal defect.
    explanation: >-
      Adds common-variant association evidence across NKX2-5, GATA4, and TBX5.
      Graded PARTIAL because this is a small case-control series reporting
      genotype frequencies, not a causal assignment.
  downstream:
  - target: Interventricular Communication
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Failure of the septation program leaves the interventricular septum
      incompletely formed.
    hypothesis_groups:
    - transcriptional_network_lesion
    evidence:
    - reference: PMID:12845333
      reference_title: "GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        These results implicate GATA4 as a genetic cause of human cardiac septal
        defects, perhaps through its interaction with TBX5.
      explanation: >-
        Supports the causal route from disruption of the cardiac transcription
        factor network to a septal defect.
- name: Stochastic Error in Cardiac Morphogenesis
  biological_scale: TISSUE
  role: trigger
  description: >
    Most ventricular septal defects have no identifiable genetic or environmental
    cause, and the epidemiology suggests this is a fact about the disease rather
    than a gap in ascertainment. Incidence is essentially flat across races,
    seasons, maternal age, birth order, sex, and socioeconomic status; known risk
    factors explain few cases; and monozygotic twins, who share genome and
    prenatal environment, are concordant only about 10% of the time. The
    inference is that many defects arise as random errors during a
    morphogenetic process whose complexity sets the error rate - a claim with
    the practical corollary that many are not preventable.
  locations:
  - preferred_term: interventricular septum
    term:
      id: UBERON:0002094
      label: interventricular septum
  biological_processes:
  - preferred_term: ventricular septum development
    term:
      id: GO:0003281
      label: ventricular septum development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:3840586
    reference_title: "Etiology of ventricular septal defects: an epidemiologic approach."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Despite identical genes and similar prenatal environments, the concordance
      rate in identical twins is only about 10%.
    explanation: >-
      The single most constraining observation for any deterministic account of
      causation, genetic or environmental.
  - reference: PMID:3840586
    reference_title: "Etiology of ventricular septal defects: an epidemiologic approach."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The consistency of incidence among individuals with widely differing genes
      and environments and the frequency of discordance in identical twins
      suggest that VSDs often occur as random errors in development, at a
      frequency largely determined by the complexity of normal cardiac
      morphogenesis.
    explanation: >-
      States the stochastic-error hypothesis this node encodes, with its
      supporting epidemiological reasoning.
  - reference: PMID:3840586
    reference_title: "Etiology of ventricular septal defects: an epidemiologic approach."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The several known risk factors for VSD, including a family history of
      congenital heart disease and exposure to certain drugs, infectious agents,
      and maternal metabolic disturbances, explain few cases.
    explanation: >-
      Supports the claim that identified causes account for a minority of
      defects.
  downstream:
  - target: Interventricular Communication
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      A stochastic failure of septal closure during morphogenesis leaves a
      communication; the intermediates are by hypothesis not systematic.
    hypothesis_groups:
    - stochastic_developmental_error
    evidence:
    - reference: PMID:3840586
      reference_title: "Etiology of ventricular septal defects: an epidemiologic approach."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The consistency of incidence among individuals with widely differing
        genes and environments and the frequency of discordance in identical
        twins suggest that VSDs often occur as random errors in development, at
        a frequency largely determined by the complexity of normal cardiac
        morphogenesis.
      explanation: >-
        Directly states the stochastic developmental route to ventricular
        septal defect represented by this edge.
- name: Interventricular Communication
  biological_scale: TISSUE
  description: >
    The anatomic lesion: a communication between the ventricular chambers. Its
    location is the single strongest determinant of what happens next. Muscular
    defects, entirely bordered by septal muscle, close spontaneously in the large
    majority of cases as the muscular septum grows and remodels around them.
    Perimembranous defects, which abut the fibrous membranous septum, close far
    less often. Size matters within subtype - perimembranous defects of 4 mm or
    more are those that do not close - but subtype dominates.
  locations:
  - preferred_term: interventricular septum
    term:
      id: UBERON:0002094
      label: interventricular septum
  evidence:
  - reference: PMID:38857582
    reference_title: "The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Muscular VSDs showed significantly higher rate of spontaneous closure
      compared with perimembranous VSDs
    explanation: >-
      Establishes anatomic subtype as the determinant of outcome, the central
      claim of this node.
  - reference: PMID:31208700
    reference_title: "Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      perimembranous site and defects ≥4 mm are risk factors for VSD that do not
      spontaneously close. Independent predictive factors for perimembranous VSD
      which do not spontaneously close is defects ≥4 mm.
    explanation: >-
      Establishes subtype and size as the determinants of persistence, in that
      order.
  - reference: PMID:12206559
    reference_title: "Closure of ventricular septal defects: a study of factors influencing spontaneous and surgical closure."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The size and morphology of a ventricular septal defect are important
      determinants of spontaneous closure and to the need for surgical
      intervention. Early age at presentation, in contrast, is not predictive of
      the need for surgical intervention.
    explanation: >-
      Supports morphology and size as determinants, and specifically excludes
      early presentation as a predictor - a negative finding that matters for
      management.
  downstream:
  - target: Ventricular Septal Defect
    causal_link_type: DIRECT
    description: >-
      The deficient septal area is the defining ventricular septal defect
      phenotype.
    evidence:
    - reference: PMID:25523232
      reference_title: "Ventricular septal defect."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        We proposed that the defects are best defined as representing the area of
        deficient ventricular septation.
      explanation: >-
        Connects the anatomic communication to the defining clinical phenotype.
        Evidence source is OTHER because this is a review.
  - target: Spontaneous Defect Closure
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Muscular defects in particular are progressively occluded by growth and
      remodeling of the surrounding septal muscle. This is the majority outcome,
      not an exception.
    evidence:
    - reference: PMID:38857582
      reference_title: "The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        After 1 year, 83.5% (607 of 727) of all VSDs had closed spontaneously,
        resulting in a decrease of prevalence from 3.3% at birth to 0.5% in
        1-year old children.
      explanation: >-
        Demonstrates that spontaneous closure is the predominant downstream
        course of the anatomic defect.
  - target: Left-to-Right Shunt and Pulmonary Overcirculation
    causal_link_type: DIRECT
    description: >-
      A persistent communication permits flow from the higher-pressure left
      ventricle to the right.
    evidence:
    - reference: PMID:25523232
      reference_title: "Ventricular septal defect."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        If the hole is small, it will be hemodynamically restrictive, thus
        limiting the size of the left-to-right shunt. If the defect is not
        hemodynamically restrictive, it will be associated with significant flow
        to the lungs, and with pulmonary hypertension.
      explanation: >-
        Links persistence and hemodynamic size of the interventricular defect to
        left-to-right shunting and increased pulmonary flow. Evidence source is
        OTHER because this is a review.
- name: Spontaneous Defect Closure
  biological_scale: TISSUE
  description: >
    The commonest outcome, and the reason this disease is managed by observation
    far more often than by intervention. In an unselected newborn cohort 83.5% of
    all defects had closed by one year, dropping prevalence from 3.3% at birth to
    0.5% at age one. The subtype split is stark: muscular defects closed in 86.9%
    versus 46.9% of perimembranous. Closure begins before birth - a third of
    fetally diagnosed muscular defects close in utero.
  locations:
  - preferred_term: interventricular septum
    term:
      id: UBERON:0002094
      label: interventricular septum
  evidence:
  - reference: PMID:38857582
    reference_title: "The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      After 1 year, 83.5% (607 of 727) of all VSDs had closed spontaneously,
      resulting in a decrease of prevalence from 3.3% at birth to 0.5% in 1-year
      old children.
    explanation: >-
      Quantifies spontaneous closure and the resulting fall in prevalence in an
      unselected screened population.
  - reference: PMID:31208700
    reference_title: "Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The SC rate in those with perimembranous VSD and muscular VSD (mVSD) were
      51.4% (18 of 35) and 97.2% (70 of 72), respectively.
    explanation: >-
      Quantifies the subtype-dependent closure rates over seven years of
      follow-up.
  - reference: PMID:31928261
    reference_title: "Isolated ventricular septal defects demonstrated by fetal echocardiography: prenatal course and postnatal outcome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Spontaneous closure of the VSDs occurred prenatally in 31/64 and 3/11 of
      fetuses with muscular VSD and perimembranous VSD, respectively.
    explanation: >-
      Documents that closure begins in utero, which is why fetally detected
      defects cannot be counted as future disease.
- name: Left-to-Right Shunt and Pulmonary Overcirculation
  biological_scale: ORGANISM
  description: >
    Because systemic vascular resistance normally far exceeds pulmonary, blood
    crosses the defect from left to right, recirculating through the lungs. The
    magnitude of the shunt is set by the ratio of the two resistances together
    with defect size, not by defect size alone - which is why the shunt is small
    in the first days of life while pulmonary resistance is still high, and grows
    over the following weeks as it falls. The consequence is excess pulmonary
    blood flow and pressure, and a volume load returning to the left atrium and
    ventricle.
  locations:
  - preferred_term: pulmonary artery
    term:
      id: UBERON:0002012
      label: pulmonary artery
  evidence:
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      uncorrected left-to-right (L-R) intracardiac shunt leading to overload of
      the pulmonary circulation and a progressive increase of PVR
    explanation: >-
      States the shunt-to-overcirculation-to-rising-resistance sequence this node
      begins. Evidence source is OTHER because this is a review.
  downstream:
  - target: Left Ventricular Volume Overload and Heart Failure
    causal_link_type: DIRECT
    description: >-
      Recirculated pulmonary blood returns to the left heart as a volume load.
    evidence:
    - reference: PMID:39711769
      reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        A congenital L-R shunt, when significant, can cause volume loading of the
        right or left ventricle, with short and long-term implications in terms
        of arrhythmia, heart failure, exercise intolerance etc.
      explanation: >-
        Directly supports shunt-driven ventricular volume loading and heart
        failure. Evidence source is OTHER because this is a review.
  - target: Obstructive Pulmonary Vascular Remodeling
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Chronic exposure of the pulmonary vascular bed to increased flow and
      pressure drives remodeling of the small pulmonary arteries.
    evidence:
    - reference: PMID:39711769
      reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        the longstanding exposure of the pulmonary vascular bed to increased
        flow and pressure can result in vascular remodelling and progressive
        increase in pulmonary vascular resistance (PVR)
      explanation: >-
        Directly supports pulmonary overcirculation as the driver of vascular
        remodeling. Evidence source is OTHER because this is a review.
  - target: Failure to Thrive
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Increased pulmonary flow raises the work of breathing and reduces systemic
      flow, increasing caloric needs while impairing feeding and growth.
    evidence:
    - reference: PMID:25523232
      reference_title: "Ventricular septal defect."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Retardation of growth is a major ... The increase in the work of
        breathing ... results in the need for increased caloric ... which cannot
        be met during infancy.
      explanation: >-
        Supports the causal route from pulmonary overcirculation through
        increased respiratory work to impaired growth. Evidence source is OTHER
        because this is a review.
  - target: Tachypnea
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Pulmonary arterial engorgement, pulmonary edema, and airway compression
      reduce lung compliance and produce rapid breathing.
    evidence:
    - reference: PMID:25523232
      reference_title: "Ventricular septal defect."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        The engorgement of the pulmonary arterial circulation may cause
        pulmonary oedema ... results in lower airway disease, and produces the
        symptoms of wheezing, tachypnea
      explanation: >-
        Directly supports the pulmonary-overcirculation route to tachypnea.
        Evidence source is OTHER because this is a review.
  - target: Cardiomegaly
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      A significant shunt produces chamber enlargement visible as cardiomegaly.
    evidence:
    - reference: PMID:25523232
      reference_title: "Ventricular septal defect."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Cardiomegaly is the rule in such instances.
      explanation: >-
        Supports cardiomegaly as a consequence of a hemodynamically significant
        left-to-right shunt. Evidence source is OTHER because this is a review.
  - target: Heart Murmur
    causal_link_type: DIRECT
    description: >-
      Turbulent flow through the defect produces the characteristic murmur.
    evidence:
    - reference: PMID:25523232
      reference_title: "Ventricular septal defect."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        A murmur is also present due to increased pulmonary flow.
      explanation: >-
        Directly attributes the murmur to increased flow through a significant
        defect. Evidence source is OTHER because this is a review.
- name: Left Ventricular Volume Overload and Heart Failure
  biological_scale: ORGANISM
  description: >
    The left ventricle handles the recirculating volume by dilating, and in a
    large defect this presents in infancy as congestive heart failure -
    tachypnoea, sweating with feeds, poor weight gain - typically after the first
    few weeks, once falling pulmonary resistance has allowed the shunt to grow.
    Failure to thrive in this setting is a haemodynamic sign rather than a
    nutritional one.
  locations:
  - preferred_term: heart left ventricle
    term:
      id: UBERON:0002084
      label: heart left ventricle
  evidence:
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A congenital L-R shunt, when significant, can cause volume loading of the
      right or left ventricle, with short and long-term implications in terms of
      arrhythmia, heart failure, exercise intolerance etc.
    explanation: >-
      Links a significant congenital left-to-right shunt to ventricular volume
      loading and heart failure, the claim of this node. Evidence source is OTHER
      because this is a review.
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the symptoms typically become ... between the ages of 4 and 8 weeks ...
      Retardation of growth is a major ... The increase in the work of breathing
      ... results in the need for increased caloric ... which cannot be met
      during infancy.
    explanation: >-
      Supports the delayed infant presentation and growth consequences of a
      hemodynamically significant defect. Evidence source is OTHER because this
      is a review.
  downstream:
  - target: Congestive Heart Failure
    causal_link_type: DIRECT
    description: >-
      Volume loading of the left ventricle beyond its compensatory capacity
      manifests as congestive heart failure in infancy.
    evidence:
    - reference: PMID:39711769
      reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        A congenital L-R shunt, when significant, can cause volume loading of the
        right or left ventricle, with short and long-term implications in terms
        of arrhythmia, heart failure, exercise intolerance etc.
      explanation: >-
        Supports heart failure downstream of shunt-driven ventricular volume
        loading. Evidence source is OTHER because this is a review.
- name: Obstructive Pulmonary Vascular Remodeling
  biological_scale: TISSUE
  conforms_to: "pulmonary_vascular_remodeling#Obstructive Pulmonary Vascular Remodeling"
  description: >
    Longstanding exposure to increased pulmonary flow and pressure remodels the
    pulmonary vascular bed. Endothelial injury and the module-conserved smooth
    muscle response progressively narrow the small pulmonary vessels and raise
    pulmonary vascular resistance. This node conforms to the conserved central effector of the
    `pulmonary_vascular_remodeling` module, substituting shunt overcirculation
    for the BMPR2 lesion or acquired endothelial injury that trigger it in other
    forms of pulmonary arterial hypertension. It is the point of no return: the
    remodeling is what makes the disease irreversible, and once it is severe the
    haemodynamics that follow cannot be undone by closing the defect.
  locations:
  - preferred_term: pulmonary artery
    term:
      id: UBERON:0002012
      label: pulmonary artery
  cell_types:
  - preferred_term: pulmonary artery smooth muscle cell
    term:
      id: CL:0000192
      label: smooth muscle cell
  - preferred_term: pulmonary artery endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  biological_processes:
  - preferred_term: blood vessel remodeling
    term:
      id: GO:0001974
      label: blood vessel remodeling
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the longstanding exposure of the pulmonary vascular bed to increased flow
      and pressure can result in vascular remodelling and progressive increase in
      pulmonary vascular resistance (PVR)
    explanation: >-
      Directly links shunt overcirculation to pulmonary vascular remodeling and
      rising resistance, the mechanism this conforming node instantiates.
      Evidence source is OTHER because this is a review.
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the increase in ... blood flow, and raised ... pressures, will produce
      endothelial damage, and permanent changes in ... resistance.
    explanation: >-
      Directly supports endothelial injury and persistent resistance change in
      the shunt-exposed pulmonary vascular bed. Evidence source is OTHER because
      this is a review.
  downstream:
  - target: Shunt Reversal and Eisenmenger Syndrome
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Rising pulmonary vascular resistance progressively narrows, then reverses,
      the interventricular pressure gradient.
    evidence:
    - reference: PMID:25523232
      reference_title: "Ventricular septal defect."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        When pulmonary vascular ... exceeds systemic vascular resistance, flow
        will be from right to left. ... Eisenmenger ... will make the patient
        inoperable.
      explanation: >-
        Directly supports resistance-driven shunt reversal and Eisenmenger
        physiology. Evidence source is OTHER because this is a review.
  - target: Pulmonary Arterial Hypertension
    causal_link_type: DIRECT
    description: >-
      Progressive vascular remodeling raises pulmonary vascular resistance and
      hence pulmonary arterial pressure.
    evidence:
    - reference: PMID:39711769
      reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        the longstanding exposure of the pulmonary vascular bed to increased
        flow and pressure can result in vascular remodelling and progressive
        increase in pulmonary vascular resistance (PVR)
      explanation: >-
        Supports pulmonary vascular remodeling as the source of progressively
        elevated resistance. Evidence source is OTHER because this is a review.
- name: Shunt Reversal and Eisenmenger Syndrome
  biological_scale: ORGANISM
  description: >
    When pulmonary vascular resistance rises to severe levels behind a large
    unrepaired post-tricuspid shunt, the direction of flow becomes bidirectional
    and then right to left. Deoxygenated blood enters the systemic circulation,
    producing cyanosis, secondary erythrocytosis, and multiorgan involvement.
    The clinically decisive point is that the defect has changed role: it is now
    the escape route for a suprasystemic right ventricle, and closing it is
    contraindicated rather than merely futile.
  locations:
  - preferred_term: interventricular septum
    term:
      id: UBERON:0002094
      label: interventricular septum
  evidence:
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Eisenmenger syndrome, appearing when a large post-tricuspid shunt is left
      uncorrected and pulmonary vascular disease (PVD) is severe, so the shunt
      becomes bidirectional or right-to-left, causing cyanosis
    explanation: >-
      Defines the syndrome and the shunt reversal that constitutes it. Evidence
      source is OTHER because this is a review.
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Closing the defects is contraindicated
    explanation: >-
      The reversal of therapeutic logic this node turns on, stated in the
      guideline-derived classification of Eisenmenger syndrome. Evidence source
      is OTHER because this is a review.
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      experts believe that the right ventricle of many Eisenmenger patients is
      optimally adapted to the increased afterload and is "unloaded" by R-L
      shunting though the unrepaired defect, supporting cardiac output at the
      expense of cyanosis.
    explanation: >-
      Supports the role of the reversed shunt as a right-ventricular pressure
      relief route. Evidence source is OTHER because this is a review.
  downstream:
  - target: Cyanosis
    causal_link_type: DIRECT
    description: >-
      Right-to-left flow delivers deoxygenated blood into the systemic
      circulation.
    evidence:
    - reference: PMID:39711769
      reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Eisenmenger syndrome, appearing when a large post-tricuspid shunt is left
        uncorrected and pulmonary vascular disease (PVD) is severe, so the shunt
        becomes bidirectional or right-to-left, causing cyanosis
      explanation: >-
        Directly supports cyanosis downstream of bidirectional or right-to-left
        shunting. Evidence source is OTHER because this is a review.
  - target: Polycythemia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Chronic hypoxaemia drives a compensatory secondary erythrocytosis.
    evidence:
    - reference: PMID:39711769
      reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Chronic cyanosis is associated with haematological changes, such as
        secondary erythrocytosis, thrombocytopenia, predisposition to bleeding
        and thrombosis
      explanation: >-
        Supports secondary erythrocytosis downstream of chronic cyanosis.
        Evidence source is OTHER because this is a review.
phenotypes:
- category: Cardiovascular
  name: Ventricular Septal Defect
  description: >
    The defining communication between the ventricles.
  phenotype_term:
    preferred_term: Ventricular septal defect
    term:
      id: HP:0001629
      label: Ventricular septal defect
  frequency: OBLIGATE
  evidence:
  - reference: PMID:38857582
    reference_title: "The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The prevalence of VSDs in unselected newborns was 3.3%.
    explanation: >-
      Establishes the defect in an unselected screened newborn population.
- category: Cardiovascular
  name: Congestive Heart Failure
  description: >
    Infant heart failure from left ventricular volume overload in a large
    left-to-right shunt.
  phenotype_term:
    preferred_term: Congestive heart failure
    term:
      id: HP:0001635
      label: Congestive heart failure
  evidence:
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      A congenital L-R shunt, when significant, can cause volume loading of the
      right or left ventricle, with short and long-term implications in terms of
      arrhythmia, heart failure, exercise intolerance etc.
    explanation: >-
      Attributes heart failure to shunt-driven ventricular volume loading.
      Evidence source is OTHER because this is a review.
- category: Growth
  name: Failure to Thrive
  description: >
    Poor weight gain in infancy, a haemodynamic consequence of shunt-related
    heart failure and increased work of breathing rather than of inadequate
    intake.
  phenotype_term:
    preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  evidence:
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Retardation of growth is a major ... The increase in the work of breathing
      ... results in the need for increased caloric ... which cannot be met
      during infancy.
    explanation: >-
      Directly supports impaired growth from pulmonary overcirculation and
      increased work of breathing in ventricular septal defect. Evidence source
      is OTHER because this is a review.
- category: Cardiovascular
  name: Pulmonary Arterial Hypertension
  description: >
    Elevated pulmonary arterial pressure and resistance from shunt-driven
    vascular remodeling.
  phenotype_term:
    preferred_term: Pulmonary arterial hypertension
    term:
      id: HP:0002092
      label: Pulmonary arterial hypertension
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Pulmonary arterial hypertension (PAH) is defined as increase in mean
      pulmonary arterial pressure and pulmonary vascular resistance (PVR). It can
      be associated with congenital heart disease (CHD)
    explanation: >-
      Establishes pulmonary arterial hypertension as a recognized congenital
      heart disease association. Evidence source is OTHER because this is a
      review.
- category: Cardiovascular
  name: Cyanosis
  description: >
    Central cyanosis appearing once the shunt reverses in Eisenmenger syndrome,
    more evident on physical activity.
  phenotype_term:
    preferred_term: Cyanosis
    term:
      id: HP:0000961
      label: Cyanosis
  evidence:
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Chronic hypoxaemia manifests as cyanosis, which can be mild or severe and
      is more evident on physical activity.
    explanation: >-
      Attributes cyanosis to chronic hypoxaemia following shunt reversal and
      notes its exertional accentuation. Evidence source is OTHER because this is
      a review.
- category: Hematologic
  name: Polycythemia
  description: >
    Secondary erythrocytosis driven by chronic hypoxaemia in Eisenmenger
    syndrome, part of a broader haematological disturbance that also predisposes
    to bleeding and thrombosis.
  phenotype_term:
    preferred_term: Polycythemia
    term:
      id: HP:0001901
      label: Polycythemia
  evidence:
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Chronic cyanosis is associated with haematological changes, such as
      secondary erythrocytosis, thrombocytopenia, predisposition to bleeding and
      thrombosis
    explanation: >-
      Documents secondary erythrocytosis as a consequence of chronic cyanosis,
      alongside the paradoxical bleeding-and-thrombosis phenotype. Evidence
      source is OTHER because this is a review.
- category: Cardiovascular
  name: Heart Murmur
  description: >
    A common presenting sign outside screening programmes. In a large defect
    with low pulmonary resistance the murmur is harsh and holosystolic; in a
    restrictive defect it is typically loud and may have a thrill. With high
    pulmonary vascular resistance, a murmur may be absent.
  phenotype_term:
    preferred_term: Heart murmur
    term:
      id: HP:0030148
      label: Heart murmur
  evidence:
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the murmur is harsh and holosystolic.
    explanation: >-
      Supports a characteristic murmur specifically in ventricular septal
      defect. Evidence source is OTHER because this is a review.
- category: Cardiovascular
  name: Tachypnea
  description: >
    Rapid breathing in the infant with a large left-to-right shunt, driven by
    pulmonary overcirculation and increased lung water rather than by primary
    lung disease.
  phenotype_term:
    preferred_term: Tachypnea
    term:
      id: HP:0002789
      label: Tachypnea
  evidence:
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The engorgement of the pulmonary arterial circulation may cause pulmonary
      oedema ... results in lower airway disease, and produces the symptoms of
      wheezing, tachypnea
    explanation: >-
      Directly supports tachypnea from pulmonary overcirculation in ventricular
      septal defect. Evidence source is OTHER because this is a review.
- category: Abdominal
  name: Hepatomegaly
  description: >
    Liver enlargement can accompany systemic venous congestion in an infant
    with shunt-related heart failure.
  phenotype_term:
    preferred_term: Hepatomegaly
    term:
      id: HP:0002240
      label: Hepatomegaly
  notes: >
    Retained as an established bedside manifestation of infant heart failure,
    but intentionally left without an evidence block or graph edge because no
    cached source in this entry documents hepatomegaly specifically in
    ventricular septal defect.
- category: Respiratory
  name: Recurrent Respiratory Infections
  description: >
    Recurrent lower respiratory tract infections can complicate a large shunt
    with chronic pulmonary overcirculation.
  phenotype_term:
    preferred_term: Recurrent respiratory infections
    term:
      id: HP:0002205
      label: Recurrent respiratory infections
  notes: >
    Retained for clinical completeness but intentionally left without an
    evidence block or graph edge because no cached source in this entry
    documents recurrent respiratory infection specifically in ventricular
    septal defect.
- category: Cardiovascular
  name: Cardiomegaly
  description: >
    Chamber enlargement from chronic volume loading of the left heart.
  phenotype_term:
    preferred_term: Cardiomegaly
    term:
      id: HP:0001640
      label: Cardiomegaly
  evidence:
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Cardiomegaly is the rule in such instances.
    explanation: >-
      Directly supports cardiomegaly in hemodynamically significant ventricular
      septal defect. Evidence source is OTHER because this is a review.
mechanistic_hypotheses:
- hypothesis_group_id: stochastic_developmental_error
  hypothesis_label: Stochastic morphogenetic error
  status: ALTERNATIVE
  description: >
    Most ventricular septal defects arise as random errors during a complex
    morphogenetic process, at a rate set by that complexity rather than by any
    particular genetic or environmental exposure. The prediction is that
    incidence should be largely invariant across populations and exposures and
    that monozygotic twins should be substantially discordant - both of which are
    observed. This remains an epidemiologically supported hypothesis rather than
    a demonstrated mechanism: somatic mutation, stochastic gene expression, or
    unmeasured micro-environmental differences could produce the same pattern.
  evidence:
  - reference: PMID:3840586
    reference_title: "Etiology of ventricular septal defects: an epidemiologic approach."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Incidence rates are similar in different races and seasons and are
      unrelated to maternal age, birth order, sex, and socioeconomic status.
    explanation: >-
      The invariance across populations and exposures that this hypothesis
      predicts.
- hypothesis_group_id: transcriptional_network_lesion
  hypothesis_label: Cardiac transcription factor network lesion
  status: ALTERNATIVE
  description: >
    In a minority of cases, and disproportionately in familial ones, the defect
    results from a specific lesion in the GATA4-NKX2-5-TBX5 septation network.
    This account explains far fewer cases than the stochastic one but explains
    them far better, and is the only branch that currently supports mechanistic
    prediction, family counselling, or modeling. The mouse work makes the
    relationship between the two accounts explicit: even a defined Nkx2-5
    mutation produces a variable phenotype governed by modifier loci, so
    "genetic cause" and "stochastic variability" are not competing at the level
    of the individual patient.
  evidence:
  - reference: PMID:12845333
    reference_title: "GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These results implicate GATA4 as a genetic cause of human cardiac septal
      defects, perhaps through its interaction with TBX5.
    explanation: >-
      States the network hypothesis in the terms curated here.
  - reference: PMID:22534315
    reference_title: "Complex trait analysis of ventricular septal defects caused by Nkx2-5 mutation."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The factors that modify rather than cause congenital heart disease
      substantially affect risk in predisposed individuals.
    explanation: >-
      Supports modifier-dependent penetrance of a defined causal mutation,
      reconciling the genetic and stochastic accounts. Evidence source is
      MODEL_ORGANISM because this is a mouse complex-trait analysis.
treatments:
- name: Surgical Ventricular Septal Defect Closure
  description: >
    Patch closure of the defect on cardiopulmonary bypass. Indicated for a large
    defect with heart failure or significant pulmonary overcirculation, and
    timed to precede irreversible pulmonary vascular disease. Contraindicated
    once Eisenmenger physiology is established.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_mechanisms:
  - target: Left-to-Right Shunt and Pulmonary Overcirculation
    treatment_effect: INHIBITS
    description: >-
      Closing the communication abolishes the shunt and the pulmonary
      overcirculation that drives vascular remodeling.
  evidence:
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Surgical closure of large and non-restrictive defects ... in the setting of
      failure to thrive and symptoms of excessive pulmonary blood flow. ... the
      recommendation is usually to close these defects before the infant reaches
      one year of age.
    explanation: >-
      Supports closure of symptomatic large defects before pulmonary vascular
      disease develops. Evidence source is OTHER because this is a review.
  - reference: PMID:12206559
    reference_title: "Closure of ventricular septal defects: a study of factors influencing spontaneous and surgical closure."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Surgical closure was required in 41 (14%) cases, and 155 (54%) defects
      closed spontaneously.
    explanation: >-
      Places surgical closure in proportion against spontaneous closure in a
      followed cohort of isolated defects.
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: REFUTE
    evidence_source: OTHER
    snippet: >-
      Closing the defects is contraindicated
    explanation: >-
      Refutes closure specifically in the Eisenmenger subgroup, where the defect
      has become the pressure-relief route for a suprasystemic right ventricle.
      Evidence source is OTHER because this is a review carrying the
      guideline-derived classification.
- name: Transcatheter Device Closure
  description: >
    Catheter-delivered occluder device closure, avoiding sternotomy and bypass
    in anatomically suitable defects.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: transcatheter device closure
    term:
      id: NCIT:C49236
      label: Therapeutic Procedure
  target_mechanisms:
  - target: Left-to-Right Shunt and Pulmonary Overcirculation
    treatment_effect: INHIBITS
    description: >-
      Device occlusion abolishes the interventricular communication and its
      shunt.
  evidence:
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      both muscular and perimembranous defects can be closed percutaneously by
      insertion of devices using cardiac catheterisation
    explanation: >-
      Directly supports percutaneous device closure for anatomically suitable
      muscular and perimembranous defects. Evidence source is OTHER because this
      is a review.
  - reference: PMID:31208700
    reference_title: "Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      During the 7-year follow-up period, 18 cases required surgical or
      transcatheter closure.
    explanation: >-
      Documents transcatheter closure alongside surgery as the intervention used
      in the minority of defects that do not close spontaneously.
- name: Targeted Pulmonary Arterial Hypertension Therapy
  description: >
    Pulmonary vasodilator therapy, used both to treat established pulmonary
    arterial hypertension and, in a "treat and repair" strategy, to lower
    pulmonary vascular resistance far enough to bring a borderline patient back
    within operability criteria.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: bosentan
      term:
        id: CHEBI:51450
        label: bosentan
    - preferred_term: sildenafil
      term:
        id: CHEBI:9139
        label: sildenafil
  target_mechanisms:
  - target: Obstructive Pulmonary Vascular Remodeling
    treatment_effect: MODULATES
    description: >-
      Pulmonary vasodilator therapy lowers the functional component of pulmonary
      vascular resistance; it does not imply reversal of fixed structural
      remodeling.
  evidence:
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Others may benefit from a "treat and repair" strategy, which involves the
      use of PAH therapy to achieve a drop in PVR, with the aim of achieving
      operability criteria.
    explanation: >-
      Supports the treat-and-repair rationale. Graded PARTIAL because the source
      states it as a strategy some patients may benefit from, not as an
      established indication with demonstrated outcomes. Evidence source is OTHER
      because this is a review.
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      There is now evidence to support a sustained, long-term beneficial effect
      of bosentan in Eisenmenger patients
    explanation: >-
      Names the endothelin receptor antagonist curated as a therapeutic agent and
      supports a sustained effect in the Eisenmenger subgroup - the same patients
      in whom defect closure is contraindicated, which is what makes medical
      therapy the only option there.
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the phosphodiesterase type 5 inhibitors (PDE-5i), sildenafil and tadalafil,
      have also shown favourable functional and haemodynamic effects in
      Eisenmenger patients.
    explanation: >-
      Names the phosphodiesterase-5 inhibitor curated as a therapeutic agent.
      Graded PARTIAL because the source itself describes these as "less robust
      studies" than the bosentan evidence.
- name: Palliative Pulmonary Artery Banding
  description: >
    Rare palliative narrowing of the pulmonary trunk to reduce pulmonary flow
    when definitive closure is not immediately feasible, particularly for
    difficult large muscular or multiple defects.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_mechanisms:
  - target: Left-to-Right Shunt and Pulmonary Overcirculation
    treatment_effect: INHIBITS
    description: >-
      Banding increases pulmonary outflow resistance and reduces pulmonary
      overcirculation without closing the defect.
  evidence:
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Only in rare cases is palliative banding of the pulmonary trunk now
      recommended.
    explanation: >-
      Supports pulmonary artery banding as a rare palliative intervention.
      Evidence source is OTHER because this is a review.
- name: ACE-Inhibitor Afterload Reduction
  description: >
    Angiotensin-converting-enzyme inhibition can reduce afterload and favor
    forward systemic output, thereby reducing left-to-right shunt volume in a
    symptomatic infant awaiting closure.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: ACE inhibitor
      term:
        id: NCIT:C247
        label: ACE Inhibitor
  target_mechanisms:
  - target: Left-to-Right Shunt and Pulmonary Overcirculation
    treatment_effect: MODULATES
    description: >-
      Systemic afterload reduction favors forward flow and reduces the shunt
      fraction without closing the communication.
  evidence:
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Afterload reduction is achieved using inhibi...tors of angiotensin
      converting enzyme.
    explanation: >-
      Directly supports ACE-inhibitor afterload reduction. Evidence source is
      OTHER because this is a review.
- name: Digoxin for Shunt-Related Heart Failure
  description: >
    Digoxin may provide inotropic support in infants with a large left-to-right
    shunt and left-ventricular volume overload, although its role is increasingly
    questioned and it is not disease-modifying.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: digoxin
      term:
        id: CHEBI:4551
        label: digoxin
  target_mechanisms:
  - target: Left Ventricular Volume Overload and Heart Failure
    treatment_effect: MODULATES
    description: >-
      Positive inotropy supports the volume-loaded ventricle without correcting
      the shunt.
  evidence:
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Inotropy through digoxin is of benefit in those patients with large ...
      shunts and volume overload of the left ventricle ... its use is increasingly
      coming under scrutiny.
    explanation: >-
      Supports digoxin while preserving the source's explicit uncertainty.
      Evidence source is OTHER because this is a review.
- name: Diuretic Therapy for Shunt-Related Heart Failure
  description: >
    Symptomatic management of the volume-overloaded infant while awaiting either
    spontaneous closure or definitive repair. It relieves the congestive
    consequences of the shunt without altering the shunt itself, which is why it
    is curated against the heart-failure node rather than against the
    communication.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: diuretic
      term:
        id: NCIT:C448
        label: Diuretic
  target_mechanisms:
  - target: Left Ventricular Volume Overload and Heart Failure
    treatment_effect: INHIBITS
    description: >-
      Diuresis reduces the circulating volume the overloaded ventricle must
      handle, relieving congestive symptoms without changing the shunt.
  evidence:
  - reference: PMID:25523232
    reference_title: "Ventricular septal defect."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      producing difficulty in feeding, diaphoresis, or tachypnea, diuretics are
      the first line of medical ...
    explanation: >-
      Directly supports diuretic treatment for symptomatic shunt-related heart
      failure. Evidence source is OTHER because this is a review.
discussions:
- discussion_id: vsd_intervention_timing_window
  kind: OPEN_QUESTION
  attaches_to:
  - "pathophysiology#Interventricular Communication"
  - "pathophysiology#Obstructive Pulmonary Vascular Remodeling"
  prompt: >
    How should the intervention window be bounded when the same defect may either
    close itself or become inoperable?
  rationale: >
    The therapeutic window in this disease is bounded on both sides, which is
    unusual. Operating too early risks intervening on a defect that would have
    closed spontaneously - the majority outcome, and 83.5% within one year in
    unselected newborns. Waiting too long allows pulmonary vascular remodeling to
    become irreversible, converting a correctable lesion into one where closure
    is contraindicated. Subtype resolves much of this (muscular defects can be
    watched; large perimembranous defects cannot), but the intermediate case -
    a moderate perimembranous defect with a growing shunt in an infant who is
    feeding adequately - is not resolved by the available data, and early age at
    presentation has been shown specifically not to predict the need for surgery.
  evidence:
  - reference: PMID:12206559
    reference_title: "Closure of ventricular septal defects: a study of factors influencing spontaneous and surgical closure."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Early age at presentation, in contrast, is not predictive of the need for
      surgical intervention.
    explanation: >-
      Removes the most intuitive triage variable from consideration, which is
      what makes the intermediate case genuinely open.
- discussion_id: vsd_stochastic_versus_undiscovered_cause
  kind: KNOWLEDGE_GAP
  attaches_to:
  - "pathophysiology#Stochastic Error in Cardiac Morphogenesis"
  prompt: >
    Is the residual, unexplained majority of ventricular septal defects genuinely
    stochastic, or does it reflect causes not yet detectable?
  rationale: >
    The stochastic account rests on negative and indirect evidence: flat
    incidence across exposures, few cases explained by known risk factors, and
    about 10% monozygotic twin concordance. Twin discordance is the strongest
    piece, but it does not distinguish true developmental noise from somatic
    mutation, stochastic gene expression, or micro-environmental differences
    between co-twins - all of which would be causes, just undetectable ones. The
    distinction is not academic: a genuinely stochastic process has an
    irreducible floor, whereas an undetected cause could in principle be
    prevented. No study has applied somatic variant detection to cardiac tissue
    from discordant monozygotic twins.
  proposed_experiments:
  - experiment_id: exp_vsd_discordant_twin_somatic_variants
    name: Somatic variant analysis of cardiac tissue from monozygotic twins discordant for septal defect
    description: >-
      Apply deep somatic variant detection to cardiac tissue or
      cardiac-lineage-derived cells from monozygotic twin pairs discordant for
      ventricular septal defect. Recurrent somatic lesions in septation-pathway
      genes in the affected twin would reclassify part of the "stochastic"
      residue as a detectable cause; their absence would strengthen the
      developmental-noise interpretation.
inheritance:
- name: Sporadic occurrence
  inheritance_term:
    preferred_term: Sporadic
    term:
      id: HP:0003745
      label: Sporadic
  description: >
    The great majority of ventricular septal defects occur sporadically, with no
    family history and no identified exposure. Recurrence risk counselling rests
    on this, and on the observation that even monozygotic co-twins are usually
    discordant.
  evidence:
  - reference: PMID:3840586
    reference_title: "Etiology of ventricular septal defects: an epidemiologic approach."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Despite identical genes and similar prenatal environments, the concordance
      rate in identical twins is only about 10%.
    explanation: >-
      Supports predominantly sporadic occurrence: shared genotype does not confer
      shared phenotype.
- name: Non-Mendelian familial aggregation
  inheritance_term:
    preferred_term: Non-Mendelian inheritance
    term:
      id: HP:0001426
      label: Non-Mendelian inheritance
  description: >
    A minority of cases aggregate in families. Where a single-gene lesion in the
    GATA4-NKX2-5-TBX5 septation network is present, transmission can look
    autosomal dominant, but penetrance is modifier-dependent and the general
    pattern across families is non-Mendelian. Family history of congenital heart
    disease is a recognized risk factor that nonetheless explains few cases.
  evidence:
  - reference: PMID:3840586
    reference_title: "Etiology of ventricular septal defects: an epidemiologic approach."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The several known risk factors for VSD, including a family history of
      congenital heart disease and exposure to certain drugs, infectious agents,
      and maternal metabolic disturbances, explain few cases.
    explanation: >-
      Recognizes family history as a risk factor while establishing that it,
      like the other known factors, accounts for a minority of cases.
  - reference: PMID:22534315
    reference_title: "Complex trait analysis of ventricular septal defects caused by Nkx2-5 mutation."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The factors that modify rather than cause congenital heart disease
      substantially affect risk in predisposed individuals.
    explanation: >-
      Supports modifier-dependent penetrance, the reason familial transmission
      does not follow a clean Mendelian pattern. Evidence source is
      MODEL_ORGANISM because this is a mouse complex-trait analysis.
diagnosis:
- name: Transthoracic Echocardiography
  description: >
    Echocardiography is the diagnostic modality for ventricular septal defect and
    is what defines its modern population epidemiology: the principal birth and
    one-year prevalence estimates cited in this entry come from a cohort in which
    unselected newborns underwent echocardiography rather than being referred on
    clinical suspicion. This matters because clinical ascertainment misses many
    small muscular defects that subsequently close.
  diagnosis_term:
    preferred_term: echocardiography
    term:
      id: NCIT:C16525
      label: Echocardiography Test
  evidence:
  - reference: PMID:31208700
    reference_title: "Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We conducted a prospective study at 3 hospitals, all newborns underwent
      echocardiography.
    explanation: >-
      Establishes universal newborn echocardiography as the ascertainment method
      behind the occurrence figures curated here.
- name: Fetal Echocardiography
  description: >
    Prenatal detection by fetal echocardiography, the setting in which in-utero
    spontaneous closure is observed. Because a third of fetally diagnosed
    muscular defects close before birth, a prenatal diagnosis cannot be counted
    as a postnatal case.
  diagnosis_term:
    preferred_term: echocardiography
    term:
      id: NCIT:C16525
      label: Echocardiography Test
  evidence:
  - reference: PMID:31928261
    reference_title: "Isolated ventricular septal defects demonstrated by fetal echocardiography: prenatal course and postnatal outcome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Spontaneous closure of the VSDs occurred prenatally in 31/64 and 3/11 of
      fetuses with muscular VSD and perimembranous VSD, respectively.
    explanation: >-
      Documents prenatal detection and in-utero closure in a fetally ascertained
      cohort.
- name: Cardiac Catheterization
  description: >
    The measurement that decides operability. Echocardiography establishes the
    defect; catheterization quantifies pulmonary vascular resistance and the
    pulmonary-to-systemic flow ratio, and permits the pulmonary circulation to be
    challenged pharmacologically or the defect temporarily occluded before a
    decision is made. This entry's whole Eisenmenger and treat-and-repair
    reasoning depends on those numbers, so the diagnostic modality that produces
    them belongs here rather than being implied.
  diagnosis_term:
    preferred_term: cardiac catheterization
    term:
      id: NCIT:C38044
      label: Cardiac Catheterization
  evidence:
  - reference: PMID:39711769
    reference_title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Cardiac catheterization is at the center of the evaluation and follow-up of
      these patients, collecting "baseline" data and providing the opportunity to
      challenge the pulmonary circulation, manipulate the loading status, or
      temporarily occlude the defect.
    explanation: >-
      States the central role of catheterization in the evaluation on which
      operability is judged. Evidence source is OTHER because this is a review.
prevalence:
- population: Unselected newborns screened by echocardiography
  measure_type: BIRTH_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 3300.0
  notes: 3.3% of 25,556 newborns in a universal screening cohort.
  evidence:
  - reference: PMID:38857582
    reference_title: "The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The prevalence of VSDs in unselected newborns was 3.3%.
    explanation: >-
      Birth prevalence from universal newborn echocardiographic screening.
- population: One-year-old children, same screening cohort
  measure_type: POINT_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 500.0
  notes: >-
    0.5% at age one after spontaneous closure. Recorded separately from the birth
    figure because the two are not comparable: most of the difference is closure,
    not ascertainment.
  evidence:
  - reference: PMID:38857582
    reference_title: "The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      ultimately resulting in a prevalence of VSD in 1-year-old children of 0.5%.
    explanation: >-
      Point prevalence at one year in the same cohort.
- population: Chinese newborns screened by echocardiography
  measure_type: BIRTH_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 1674.0
  notes: >-
    113 of 6,750 screened newborns (16.74 per 1,000); rounded to 1,674 per
    100,000.
  evidence:
  - reference: PMID:31208700
    reference_title: "Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 6,750 newborns, VSDs were detected in 113 cases
    explanation: >-
      Supplies the numerator and denominator for the birth-prevalence estimate.
epidemiology:
- name: Prevalence in unselected newborns and fall after spontaneous closure
  description: >
    Screening echocardiography in unselected newborns finds a ventricular septal
    defect in about 3.3%, falling to 0.5% by age one as most close spontaneously.
  evidence:
  - reference: PMID:38857582
    reference_title: "The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The prevalence of VSDs in unselected newborns was 3.3%.
    explanation: >-
      Birth prevalence from universal newborn echocardiographic screening.
  - reference: PMID:38857582
    reference_title: "The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      ultimately resulting in a prevalence of VSD in 1-year-old children of 0.5%.
    explanation: >-
      The one-year prevalence after spontaneous closure, which is what makes
      birth-prevalence and childhood-prevalence figures non-comparable.
- name: Share of congenital heart disease in newborn screening
  description: >
    Ventricular septal defects accounted for 62.8% of congenital heart disease
    detected by universal newborn echocardiographic screening.
  evidence:
  - reference: PMID:31208700
    reference_title: "Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      accounting for 62.8% of congenital heart disease
    explanation: >-
      Quantifies the share of congenital heart disease attributable to
      ventricular septal defect in a screened newborn population.
genetic:
- name: GATA4
  gene_term:
    preferred_term: GATA4
    term:
      id: hgnc:4173
      label: GATA4
  relationship_type: CAUSATIVE
  notes: >
    Heterozygous GATA4 missense (G296S) and frameshift (E359del) mutations
    segregate with isolated cardiac septal defects in large pedigrees, acting
    through reduced transcriptional activity and loss of the GATA4-TBX5
    interaction.
  evidence:
  - reference: PMID:12845333
    reference_title: "GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In a second family, we identified a frame-shift mutation of GATA4 (E359del)
      that was transcriptionally inactive and segregated with cardiac septal
      defects.
    explanation: >-
      Independent segregating mutation in a second pedigree, which is what raises
      this from association to causation.
- name: NKX2-5
  gene_term:
    preferred_term: NKX2-5
    term:
      id: hgnc:2488
      label: NKX2-5
  relationship_type: CAUSATIVE
  notes: >
    NKX2-5 was the first gene identified by linkage in non-syndromic congenital
    heart defects. Mouse work shows that even a defined Nkx2-5 mutation yields a
    phenotype whose penetrance depends heavily on modifier loci.
  evidence:
  - reference: PMID:12845333
    reference_title: "GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Only one causative gene, NKX2-5, has been identified through genetic
      linkage analysis of pedigrees with non-syndromic CHDs.
    explanation: >-
      Establishes NKX2-5 as a linkage-identified causative gene for non-syndromic
      congenital heart defects.
- name: TBX5
  gene_term:
    preferred_term: TBX5
    term:
      id: hgnc:11604
      label: TBX5
  relationship_type: CAUSATIVE
  notes: >
    TBX5 is responsible for a subset of syndromic cardiac septal defects, and the
    specific missense mutations that cause them disrupt the same GATA4-TBX5
    interaction that GATA4 mutations abolish from the other side.
  evidence:
  - reference: PMID:12845333
    reference_title: "GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      interaction of Gata4 and TBX5 was disrupted by specific human TBX5 missense
      mutations that cause similar cardiac septal defects.
    explanation: >-
      Establishes that disease-causing TBX5 mutations converge on the same
      protein-protein interaction. Evidence source is IN_VITRO because the
      interaction was assayed biochemically.
animal_models:
- name: Nkx2-5(+/-) heterozygous knockout mouse
  species: Mus musculus
  genotype: Nkx2-5(+/-) heterozygous knockout on a C57BL/6 x FVB/N second-generation intercross
  category: Genetic model with mapped modifier loci
  publication: PMID:22534315
  modeled_mechanisms:
  - target: Cardiac Septation Transcriptional Program Disruption
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      A heterozygous null allele of a curated human septation-network gene
      produces ventricular septal defects in the mouse, which is the mechanism
      this node asserts.
  - target: Stochastic Error in Cardiac Morphogenesis
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    limitations: >-
      The model shows that the residual variance has structure - mapped modifier
      loci and a maternal-age effect - which is not the same claim as irreducible
      developmental noise. It demonstrates that defect occurrence is incompletely
      determined by genotype; it does not establish that the human residual is
      stochastic rather than merely undetected.
    description: >-
      Same-genotype littermates differ in whether a defect forms, and the
      variation is attributable to modifier loci and to maternal age rather than
      to the causal mutation - the experimental analogue of the discordance
      between monozygotic human twins.
  description: >
    The model that makes this entry's two hypotheses compatible rather than
    competing. Phenotyping over 3,100 hearts from an intercross of two inbred
    backgrounds carrying the same heterozygous Nkx2-5 knockout mapped modifier
    loci on chromosomes 6, 8, and 10 governing susceptibility to membranous
    defects, with the chromosome 6 locus overlapping one for muscular defect
    susceptibility. A defined causal mutation therefore does not determine
    whether a defect forms - genetic background does much of the work. The
    maternal-age finding is the sharper result: maternal age correlated with
    defect risk in Nkx2-5(+/-) animals but not in wild-type littermates,
    unrelated to aneuploidy, meaning an environmental variable acts only on a
    genetically predisposed background.
  evidence:
  - reference: PMID:22534315
    reference_title: "Complex trait analysis of ventricular septal defects caused by Nkx2-5 mutation."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Genetic linkage analysis mapped loci with lod scores of 5 to 7 on
      chromosomes 6, 8, and 10 that influence the susceptibility to membranous
      VSDs in Nkx2-5(+/-) animals.
    explanation: >-
      Establishes mapped modifier loci acting on a defined causal mutation.
      Evidence source is MODEL_ORGANISM because this is a mouse intercross.
  - reference: PMID:22534315
    reference_title: "Complex trait analysis of ventricular septal defects caused by Nkx2-5 mutation."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Multiple logistic regression analysis for environmental variables revealed
      that maternal age is correlated with the risk of membranous and muscular
      VSD in Nkx2-5(+/-) but not wild-type animals.
    explanation: >-
      The genotype-conditional environmental effect: maternal age acts only on
      the predisposed background, which is exactly the gene-environment structure
      the two curated hypotheses jointly predict.
  - reference: PMID:22534315
    reference_title: "Complex trait analysis of ventricular septal defects caused by Nkx2-5 mutation."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The risk of a VSD is not only complex but dynamic. Whereas the effect of
      genetic modifiers on risk remains constant, the effect of maternal aging
      increases over time.
    explanation: >-
      Distinguishes a constant genetic contribution from a time-varying
      environmental one, which is why neither hypothesis in this entry is framed
      as sufficient on its own.
environmental:
- name: Periconceptional folic acid supplementation
  exposure_term:
    preferred_term: periconceptional folic acid supplementation exposure
    modifier: INCREASED
    term:
      id: ECTO:9000123
      label: exposure to folic acid
  description: >
    Maternal periconceptional folic acid supplement use is associated with an
    approximately 20% lower prevalence of congenital heart defects. It acts, if
    it acts causally, during the same organogenetic window in which septation
    occurs - which is what makes it a candidate modifier of the error rate the
    stochastic account posits, rather than a treatment of an established defect.
  influences_mechanisms:
  - target: Stochastic Error in Cardiac Morphogenesis
    environmental_effect: PROTECTS_AGAINST
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Adequate periconceptional folate is proposed to lower the rate of
      morphogenetic error during septation. The intermediates are unknown and the
      association is measured at the level of congenital heart defects as a
      class, so the edge is deliberately typed as indirect with unknown
      intermediates.
    evidence:
    - reference: PMID:19952004
      reference_title: "Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Use of periconceptional folic acid supplements was related to
        approximately 20% reduction in the prevalence of any CHD.
      explanation: >-
        Quantifies the protective association. Graded PARTIAL because it is
        measured across all congenital heart defects rather than ventricular
        septal defect specifically, and because no mechanism linking folate to
        septation error is demonstrated.
  evidence:
  - reference: PMID:19952004
    reference_title: "Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our results support the hypothesis that additional periconceptional folic
      acid use reduces CHD risk in infants.
    explanation: >-
      Supports a protective association. Graded PARTIAL because the finding is
      for congenital heart defects as a class in a registry-based case-control
      design, not ventricular septal defect specifically.
- name: Maternal diabetes mellitus in pregnancy
  description: >
    Offspring of women with diabetes carry an increased risk of ventricular
    septal defect. The effect is defect-specific and quantified: a relative risk
    of 1.31 for ventricular septal defect in offspring of women with gestational
    diabetes. Pre-gestational diabetes carries a higher overall risk of
    congenital heart defects than gestational diabetes does, which is
    mechanistically coherent -
    septation occurs in weeks three to eight, before gestational hyperglycaemia
    typically develops - and is one of the few places where exposure timing and
    developmental timing can be compared directly.
  influences_mechanisms:
  - target: Stochastic Error in Cardiac Morphogenesis
    environmental_effect: PREDISPOSES
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      A diabetic intrauterine environment during organogenesis raises the
      probability of a septation error. Typed as predisposing rather than
      triggering because the great majority of exposed pregnancies produce no
      defect.
    evidence:
    - reference: PMID:35104296
      reference_title: "Risks of specific congenital anomalies in offspring of women with diabetes: A systematic review and meta-analysis of population-based studies including over 80 million births."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        ventricular septal defect (RR = 1.31, 95% CI 1.24 to 1.38, I2 = 0%, P =
        0.960)
      explanation: >-
        A defect-specific relative risk with no heterogeneity across the pooled
        population-based studies, which is what makes this stronger than the
        class-level associations elsewhere in this section.
  evidence:
  - reference: PMID:35104296
    reference_title: "Risks of specific congenital anomalies in offspring of women with diabetes: A systematic review and meta-analysis of population-based studies including over 80 million births."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The RRs of overall CAs and CHDs in offspring of women with PGDM were higher
      than those in offspring of women with GDM.
    explanation: >-
      Establishes the pre-gestational versus gestational gradient, the
      observation that lets exposure timing be compared against the
      organogenetic window.
references:
- reference: PMID:12206559
  title: "Closure of ventricular septal defects: a study of factors influencing spontaneous and surgical closure."
  findings: []
- reference: PMID:12845333
  title: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.
  findings: []
- reference: PMID:19952004
  title: "Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands."
  findings: []
- reference: PMID:22534315
  title: Complex trait analysis of ventricular septal defects caused by Nkx2-5 mutation.
  findings: []
- reference: PMID:25523232
  title: Ventricular septal defect.
  findings: []
- reference: PMID:30834692
  title: "Association of NKX2-5, GATA4, and TBX5 polymorphisms with congenital heart disease in Egyptian children."
  findings: []
- reference: PMID:31208700
  title: "Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates)."
  findings: []
- reference: PMID:31928261
  title: "Isolated ventricular septal defects demonstrated by fetal echocardiography: prenatal course and postnatal outcome."
  findings: []
- reference: PMID:35104296
  title: "Risks of specific congenital anomalies in offspring of women with diabetes: A systematic review and meta-analysis of population-based studies including over 80 million births."
  findings: []
- reference: PMID:3840586
  title: "Etiology of ventricular septal defects: an epidemiologic approach."
  findings: []
- reference: PMID:38857582
  title: The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life.
  findings: []
- reference: PMID:39711769
  title: "Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?"
  findings: []
📚

References & Deep Research

References

12
PMID:12206559
Closure of ventricular septal defects: a study of factors influencing spontaneous and surgical closure.
No top-level findings curated for this source.
PMID:12845333
GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.
No top-level findings curated for this source.
PMID:19952004
Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands.
No top-level findings curated for this source.
PMID:22534315
Complex trait analysis of ventricular septal defects caused by Nkx2-5 mutation.
No top-level findings curated for this source.
PMID:25523232
Ventricular septal defect.
No top-level findings curated for this source.
PMID:30834692
Association of NKX2-5, GATA4, and TBX5 polymorphisms with congenital heart disease in Egyptian children.
No top-level findings curated for this source.
PMID:31208700
Spontaneous Closure Rates of Ventricular Septal Defects (6,750 Consecutive Neonates).
No top-level findings curated for this source.
PMID:31928261
Isolated ventricular septal defects demonstrated by fetal echocardiography: prenatal course and postnatal outcome.
No top-level findings curated for this source.
PMID:35104296
Risks of specific congenital anomalies in offspring of women with diabetes: A systematic review and meta-analysis of population-based studies including over 80 million births.
No top-level findings curated for this source.
PMID:3840586
Etiology of ventricular septal defects: an epidemiologic approach.
No top-level findings curated for this source.
PMID:38857582
The Prevalence and Spontaneous Closure of Ventricular Septal Defects the First Year of Life.
No top-level findings curated for this source.
PMID:39711769
Pulmonary arterial hypertension with left to right shunts: When to treat and/or close?
No top-level findings curated for this source.

Deep Research

1
Claude Code ▸
Ventricular Septal Defect (VSD): Comprehensive Research Report
claude-haiku-4-5-20251001, claude-sonnet-5 32 citations 2026-08-10T14:11:14.156917

Ventricular Septal Defect (VSD): Comprehensive Research Report

1. Disease Information

Overview: Ventricular septal defect (VSD) is a congenital cardiac malformation characterized by an abnormal opening in the interventricular septum, the muscular/membranous wall separating the left and right ventricles. It is the most common congenital heart defect (CHD) in live-born infants (excluding bicuspid aortic valve), accounting for roughly 20–30% of all congenital heart lesions. VSDs range from small, hemodynamically insignificant defects that close spontaneously to large defects causing heart failure and, if untreated, pulmonary vascular disease (Eisenmenger syndrome).

Key identifiers: - MONDO: MONDO:0002070 - OMIM: 614429 (ventricular septal defect 1, VSD1; note OMIM also separately catalogs syndromic forms, e.g., under specific gene entries such as GATA4 600576, NKX2-5 600584, TBX5 601620) - Orphanet: ORPHA:1480 (isolated ventricular septal defect) - ICD-10-CM: Q21.0 (congenital VSD); I23.2 (acquired/post-MI VSD, a distinct acquired mechanical complication) - ICD-11 (MMS): LA88.4 - MeSH: D006345 (Heart Septal Defects, Ventricular) - HPO: HP:0001629 (Ventricular septal defect)

Synonyms: interventricular septal defect; VSD; "hole in the heart" (lay term); perimembranous/membranous VSD, muscular VSD, inlet (AV canal-type) VSD, outlet (conal/infundibular/doubly committed subarterial) VSD (classification by anatomic location, per STS/EACTS congenital nomenclature).

Data source note: Most quantitative claims below derive from aggregated disease-level resources — population birth-defect registries (EUROCAT, national/regional CHD registries), meta-analyses, and large clinical cohorts — rather than individual-patient EHR mining, though several cited studies (e.g., Murmansk registry, Chinese birth cohorts) are themselves registry/EHR-derived aggregates.

Sources: ICD10Data Q21.0, Wikidata Q838139

2. Etiology

Disease Causal Factors

VSD arises from failure of fusion/closure of one or more embryologic components of the interventricular septum during weeks 4–8 of gestation (see Mechanism section). Etiology is heterogeneous: isolated/non-syndromic VSD is typically considered multifactorial (polygenic + environmental), while a substantial minority occur as part of monogenic syndromes or chromosomal disorders.

Genetic Risk Factors

  • Chromosomal: Trisomy 21 (Down syndrome) — VSD (often as part of complete atrioventricular septal defect) is present in ~40–45% of Down syndrome individuals with CHD. 22q11.2 deletion syndrome (DiGeorge/velocardiofacial syndrome) — conotruncal VSDs (often malalignment-type, associated with tetralogy of Fallot, interrupted aortic arch, truncus arteriosus) occur in a meta-analysis pooled prevalence of 14% (95% CI 0.12–0.16) of 22q11.2DS individuals, with VSD as part of the broader conotruncal spectrum reported in up to 64% of some cohorts when tetralogy of Fallot/pulmonary atresia-with-VSD phenotypes are included.
  • Single-gene / transcription-factor mutations: GATA4 (HGNC:4171, OMIM 600576) — heterozygous missense mutations (e.g., G296S) cause familial ASD/VSD with interrupted GATA4–TBX5 physical interaction (Garg et al., PMID:12845333). NKX2-5 (HGNC:2488, OMIM 600584) — mutations/promoter variants found in VSD cohorts, also cause AV block and other CHD (PMID:22576768). TBX5 (HGNC:11602, OMIM 601620) — causes Holt-Oram syndrome (heart-hand syndrome), with septal defects (ASD, VSD) among its cardiac manifestations, via TBX5–GATA4 protein interaction disruption. CFC1 (Cryptic) — implicated in laterality-associated septal defects.
  • Syndromic associations: Noonan syndrome (PTPN11, RAF1, and other RAS-MAPK pathway genes), Alagille syndrome (JAG1, NOTCH2), VACTERL association, CHARGE syndrome, Ellis-van Creveld syndrome, fetal alcohol syndrome (see environmental).
  • Susceptibility loci: Genome-wide and candidate-gene studies also implicate polymorphisms in NKX2-5, GATA4, and TBX5 as modifiers/susceptibility variants in non-syndromic CHD (PMID:30834692, PMC6503026 — Egyptian cohort).

Protective Factors

  • Periconceptional folic acid supplementation is the best-documented protective/environmental factor — associated with an estimated ~20% reduction in overall CHD risk in a Dutch EUROCAT case-control study (PMID:19952004), and specifically for VSD an adjusted RR of 0.47 in a Chinese folic-acid-user cohort; Hungarian intervention data suggest periconceptional multivitamin/high-dose folic acid supplementation prevented ~40% of CHDs, with the association strongest for VSD and conotruncal defects.
  • No well-established protective genetic variants specific to VSD have been robustly replicated (in contrast to protective alleles described for some other complex diseases).

Environmental / Non-Genetic Risk Factors

  • Maternal pregestational diabetes mellitus — strong teratogenic risk factor; one case-control estimate gives OR 8.72 (95% CI 3.16–24.07) for VSD.
  • Maternal alcohol use — moderate-to-heavy periconceptional alcohol consumption associated with isolated VSD; OR 4.83 (95% CI 1.88–12.41) for alcohol abuse.
  • Maternal infections — rubella (congenital rubella syndrome classically causes PDA but also VSD), influenza, febrile illness.
  • Maternal phenylketonuria (uncontrolled, elevated phenylalanine) — teratogenic to cardiac septation.
  • Teratogenic medications/substances — retinoic acid, certain anticonvulsants, metronidazole, ibuprofen (implicated in some case-control studies), cocaine, marijuana.
  • Maternal smoking.
  • Advanced/extreme maternal age, though the classic epidemiology literature notes VSD incidence is largely unrelated to maternal age, birth order, sex, or socioeconomic status in most studies (PMID:3840586).

Gene-Environment Interactions

Folate-pathway gene polymorphisms (e.g., MTHFR, FOLR1, FOLR2) have been studied for interaction with periconceptional folate status and CHD/VSD risk (PMC10930486), though the TYMS gene specifically was not associated with septal defects in a Han Chinese cohort (PMC3285645). Maternal diabetic hyperglycemia interacting with genetic susceptibility (e.g., in the RAS-MAPK or NKX2-5 pathways) is a proposed but incompletely characterized gene-environment mechanism.

Sources: PMID:12845333 GATA4, PMID:22576768 NKX2-5, PMC12573319 22q11.2 meta-analysis, Johns Hopkins maternal lifestyle, PMC6069126 Murmansk registry, PMID:19952004 folic acid Netherlands

3. Phenotypes

Symptoms / Clinical Signs (by defect size and shunt magnitude)

Phenotype HPO term Onset Frequency/notes
Holosystolic (pansystolic) murmur, harsh, left lower sternal border HP:0030148 (Holosystolic murmur) / HP:0030148-adjacent HP:0031667 Neonatal–infancy Classic finding in small-moderate VSD; loudness inversely correlates with defect size in small VSDs ("much cry, little wool")
Tachypnea HP:0002789 Infancy (moderate–large VSD) Frequent with significant left-to-right shunt
Failure to thrive / poor weight gain HP:0001508 Infancy Common in moderate-large VSD due to increased metabolic demand and feeding difficulty
Diaphoresis with feeding HP:0031929 (Hyperhidrosis) Infancy Sign of heart failure in infants
Congestive heart failure HP:0001635 Infancy (large VSD, as pulmonary vascular resistance falls, typically 4–8 weeks of age) Frequent in unrepaired large VSD
Recurrent respiratory infections HP:0002205 (Recurrent respiratory infections) Infancy–childhood Pulmonary overcirculation predisposes to pneumonia
Failure to thrive with tachypnea/diaphoresis with feeds — Infancy Classic infant heart-failure triad
Cyanosis (late) HP:0000961 Late (years, if Eisenmenger physiology develops) Only with reversal of shunt (right-to-left)
Clubbing (late, Eisenmenger) HP:0100759 Late Sign of chronic hypoxemia
Exertional dyspnea HP:0002875 Childhood–adult With larger or uncorrected defects
Growth retardation HP:0001510 Infancy–childhood Correlates with shunt magnitude
Hepatomegaly HP:0002240 Infancy Sign of right heart failure/systemic venous congestion

Laboratory / Imaging Abnormalities

  • Elevated BNP/NT-proBNP — correlates with hemodynamically significant shunts and heart failure.
  • Echocardiographic findings — defect location/size, direction and velocity of shunt flow (color Doppler), left atrial/ventricular enlargement (volume overload), estimated pulmonary artery pressure via tricuspid regurgitant jet.
  • ECG — left ventricular hypertrophy (volume overload) in moderate-large VSD; biventricular hypertrophy if pulmonary hypertension develops.
  • Chest X-ray — cardiomegaly, increased pulmonary vascular markings (pulmonary plethora) with significant shunts.

Phenotype Characteristics

  • Age of onset: Congenital (present at birth); clinical detection ranges from prenatal (fetal echo, from ~18–24 weeks) to incidental detection in asymptomatic adults for small residual/undiagnosed defects.
  • Severity: Highly variable — trivial/small VSDs are often asymptomatic (Qp:Qs <1.5:1); moderate VSDs cause mild-moderate symptoms; large, unrestrictive VSDs (Qp:Qs >2:1) cause overt heart failure in infancy.
  • Progression: Most small muscular VSDs are stable or regress (spontaneous closure); large VSDs are progressive toward heart failure and, if uncorrected, irreversible pulmonary vascular disease (Eisenmenger syndrome) typically by 1–2 years of age in the largest defects.
  • Frequency of specific findings among affected individuals: Directly size-dependent; ~85–90% of small isolated VSDs are asymptomatic and close spontaneously; large VSDs are almost universally symptomatic if unrepaired.

Quality of Life Impact

Small, hemodynamically insignificant or spontaneously closed VSDs carry essentially normal QoL and life expectancy. Unrepaired large VSDs or those progressing to Eisenmenger syndrome carry major QoL impact: exercise intolerance, cyanosis, recurrent hospitalization, pregnancy contraindication, and reduced life expectancy. Corrected VSDs (surgical/transcatheter) generally normalize long-term QoL, though a subset have residual arrhythmia, valve regurgitation, or exercise limitation.

Sources: NCBI Bookshelf StatPearls VSD, PMID:38857582 prevalence and spontaneous closure first year

4. Genetic / Molecular Information

Causal Genes (non-syndromic and syndromic)

Gene HGNC OMIM Role
GATA4 HGNC:4171 600576 Cardiac transcription factor; missense mutations (e.g. p.Gly296Ser) cause familial ASD/VSD; disrupts GATA4-TBX5 interaction (PMID:12845333)
NKX2-5 HGNC:2488 600584 Homeobox transcription factor; promoter and coding variants found in VSD (PMID:22576768); also causes AV conduction defects
TBX5 HGNC:11602 601620 T-box transcription factor; causes Holt-Oram syndrome; interacts physically with GATA4
CFC1 (Cryptic) HGNC:1878 605194 Laterality/Nodal signaling; implicated in septal defects with heterotaxy
JAG1 / NOTCH2 HGNC:6188 / HGNC:7882 601920 / 600275 Alagille syndrome (VSD/peripheral pulmonic stenosis common)
PTPN11 / RAF1 / others — Noonan syndrome genes RAS-MAPK pathway; pulmonic stenosis, hypertrophic cardiomyopathy, and septal defects

Pathogenic Variants

  • Variant classification/type: Predominantly missense mutations in cardiac transcription factor genes (per ACMG/AMP framework, classified pathogenic/likely pathogenic via functional and segregation data — e.g., ClinVar entries for GATA4/NKX2-5/TBX5).
  • Allele frequency: Disease-causing variants in GATA4/NKX2-5/TBX5 are individually rare (private/familial) in gnomAD; common non-coding polymorphisms in these genes have been studied as susceptibility alleles in case-control association studies but effect sizes are generally modest.
  • Somatic vs germline: VSD-causing variants are germline (developmental disease); no established somatic mosaicism mechanism specific to isolated VSD, though mosaicism has been documented in some familial CHD pedigrees.
  • Functional consequences: Loss-of-function/haploinsufficiency is the predominant mechanism for GATA4, NKX2-5, and TBX5 (dose-sensitive transcription factors); dominant-negative effects also reported for some GATA4/TBX5 missense alleles that disrupt protein-protein interaction rather than DNA binding.

Modifier Genes

Sarcospan (SSPN) — genetically interacts with Nkx2-5 in mouse models to modulate penetrance/severity of muscular VSD (PMC5390293). Genetic background/modifier loci mapped to mouse chromosomes 6, 8, and 10 influence VSD susceptibility in Nkx2-5+/- mice (PMID:22534315).

Chromosomal Abnormalities

  • Trisomy 21 (Down syndrome) — most common chromosomal association with VSD/AVSD.
  • 22q11.2 deletion — conotruncal VSD spectrum.
  • Trisomy 13, Trisomy 18 — VSD frequently part of the multi-organ malformation phenotype.
  • Turner syndrome (45,X) — more classically left-sided lesions (bicuspid aortic valve, coarctation) but VSD reported.

Epigenetic Information

Epigenetic mechanisms in cardiac septation are an active research area (e.g., histone modification at cardiac transcription factor loci during second heart field development), but disease-specific DNA methylation signatures for isolated VSD are not yet well established in humans; most epigenetic CHD literature focuses on broader conotruncal/hypoplastic left heart phenotypes.

Sources: PMID:12845333, PMID:22576768, PMC5390293 Sspn-Nkx2-5, PMID:22534315 complex trait Nkx2-5

5. Environmental Information

  • Environmental/teratogenic factors: maternal diabetes (OR 8.72), maternal alcohol use (OR 4.83), phenylketonuria, retinoic acid exposure, certain medications (metronidazole, NSAIDs in some studies), organic solvent exposure (industrial/occupational, less robustly established).
  • Lifestyle factors: maternal smoking, alcohol consumption, poor glycemic control in pregestational diabetes, obesity (emerging risk factor in some cohorts), inadequate periconceptional folate intake.
  • Infectious agents: Congenital rubella syndrome (Rubella virus, NCBI Taxon 11041) is the classical infectious teratogen associated with structural CHD including VSD, though PDA and pulmonary artery stenosis are more characteristic; maternal influenza and other febrile illnesses during the critical period of cardiac septation (weeks 4–8) have also been associated with increased VSD risk in some epidemiologic studies.

Sources: PMC6069126 Murmansk risk factors, Johns Hopkins maternal lifestyle

6. Mechanism / Pathophysiology

Embryologic/Developmental Causal Chain

The interventricular septum forms through coordinated fusion of at least three embryologic components between roughly the 5th and 8th weeks of gestation: 1. Muscular (trabecular) septum — grows upward from the ventricular floor. 2. Membranous septum — derives from the fusion of endocardial cushion tissue with the conotruncal (outflow tract) ridges. 3. Inlet septum — formed by the endocardial cushions during atrioventricular canal septation. 4. Outlet (infundibular/conal) septum — formed by fusion/rotation of the conotruncal ridges as they spiral to separate the aorta and pulmonary trunk.

Failure of fusion at any of these sites produces a VSD classified by anatomic location: perimembranous (most common, ~80% of clinically significant VSDs, at the junction of muscular and membranous septum, often adjacent to the tricuspid/aortic valves), muscular (most common type overall, including small trabecular defects, high spontaneous closure rate), inlet (AV-canal type, often associated with AVSD/Down syndrome), and outlet/doubly-committed subarterial (conotruncal, associated with 22q11.2 deletion and often with aortic cusp prolapse/aortic regurgitation).

Cellular Processes

Second heart field (SHF)-derived cardiomyocyte proliferation and migration are essential for septal myocardial growth; impaired cardiomyocyte proliferation (e.g., via reduced Cdk4/Cdk2 activity downstream of Gata4/Tbx5 haploinsufficiency) produces thin, incompletely fused septal myocardium (PMC3349729, academic.oup.com/hmg article). Endocardial cushion mesenchymal transformation (epithelial-to-mesenchymal transition, EMT) is required for inlet/membranous septation; disruption of this process (e.g., in Down syndrome-associated AVSD) contributes to septal defects.

Molecular Pathways

  • Cardiac transcription factor network: GATA4–NKX2-5–TBX5 form a cooperative transcriptional complex regulating downstream cardiac structural and cell-cycle genes; GATA4 and TBX5 directly activate Cdk4, and TBX5 alone activates Cdk2, linking this network to septal myocardial proliferation.
  • NOTCH signaling — critical for endocardial cushion EMT and outflow tract septation (relevant to Alagille syndrome-associated VSD).
  • RAS-MAPK pathway — implicated in Noonan-syndrome-associated septal and valvar defects.
  • Nodal/Cryptic (CFC1) signaling — left-right patterning pathway relevant to laterality-associated conotruncal/septal defects.

Suggested GO terms: GO:0003281 (ventricular septum development), GO:0003148 (outflow tract septum morphogenesis), GO:0003203 (endocardial cushion morphogenesis), GO:0061036 (positive regulation of cardiac muscle cell proliferation).

Protein Dysfunction

Loss-of-function/haploinsufficiency of dose-sensitive cardiac transcription factors (GATA4, NKX2-5, TBX5) is the principal molecular mechanism identified to date; these are DNA-binding transcriptional regulators whose reduced dosage or disrupted protein-protein interaction (rather than misfolding/aggregation, which is not a feature of this disease class) impairs target gene activation during septal myocardial development.

Pathophysiologic Consequence — Hemodynamics (postnatal)

Once a VSD is present, the causal chain from anatomic defect to clinical manifestation is: 1. Structural defect in ventricular septum (persists from embryogenesis) → 2. Communication between high-pressure LV and lower-pressure RV → 3. Left-to-right shunt (shunt magnitude determined by defect size + relative pulmonary vs. systemic vascular resistance) → 4. Increased pulmonary blood flow (pulmonary overcirculation) and LA/LV volume overload → 5. (If large/unrestrictive and uncorrected) chronic pulmonary vascular remodeling → progressively rising pulmonary vascular resistance → 6. Shunt reversal (right-to-left) once pulmonary vascular resistance exceeds systemic resistance → Eisenmenger syndrome (cyanosis, clubbing, irreversible pulmonary hypertension, inoperability).

This same convergent cascade (endothelial dysfunction → PASMC proliferation/vasoconstriction → obstructive pulmonary vascular remodeling → increased PVR) is captured generically in the dismech pulmonary_vascular_remodeling module and is directly applicable as the downstream consequence node for large/uncorrected VSD.

Tissue Damage / Downstream Organ Involvement

Chronic pulmonary overcirculation causes pulmonary vascular smooth muscle hypertrophy and eventual plexiform arteriopathy (irreversible pulmonary vascular disease). Chronic RV volume/pressure overload can progress to right ventricular hypertrophy and failure. Aortic cusp prolapse (particularly right coronary cusp) with resultant aortic regurgitation is a recognized complication of outlet/perimembranous VSDs due to loss of septal support beneath the aortic valve (Venturi effect).

Molecular/Omics Profiling

Single-cell and spatial transcriptomic atlases of the developing human and mouse heart (e.g., Human Developmental Cell Atlas) have profiled second heart field and endocardial cushion populations relevant to septation, though disease-specific (VSD-patient-derived) single-cell data are limited; most mechanistic single-cell work is in animal/iPSC-cardiomyocyte models rather than direct human VSD tissue, given the fetal/embryonic timing of the causal lesion.

Sources: UNSW Embryology VSD, StatPearls VSD, Oxford HMG Gata4/Tbx5 disruption, PMC3349729 Gata4 functional deficits

7. Anatomical Structures Affected

Organ Level

  • Primary: Heart, specifically the interventricular septum (UBERON:0002094, interventricular septum).
  • Secondary/complication-driven: Lungs (pulmonary vasculature, in chronic overcirculation/pulmonary hypertension — UBERON:0002048), right ventricle (UBERON:0002080, secondary hypertrophy/failure), left atrium and left ventricle (UBERON:0002079/UBERON:0002084/UBERON:0002078/UBERON:0006631, volume overload/dilation), aortic valve (UBERON:0002137, cusp prolapse/regurgitation in outlet VSD), liver (UBERON:0002107, congestive hepatomegaly in heart failure).
  • Body systems: Cardiovascular system primarily; respiratory system secondarily (pulmonary overcirculation, recurrent infections); hepatic/systemic venous congestion in decompensated heart failure.

Tissue and Cell Level

  • Cardiac myocytes (CL:0000746, cardiac muscle cell) — septal myocardial tissue, site of the primary developmental defect.
  • Endocardial cushion mesenchymal cells (CL:0002350-adjacent, endocardial cell/cushion mesenchyme) — involved in inlet/membranous septum formation.
  • Second heart field progenitor cells — contribute to outflow tract/conal septum.
  • Pulmonary vascular smooth muscle cells (CL:0000359, pulmonary artery smooth muscle cell) — remodel in chronic pulmonary hypertension/Eisenmenger physiology.
  • Cardiac fibroblasts — involved in septal connective tissue and, secondarily, in any reparative/scarring response post-surgical closure.

Subcellular Level

GO Cellular Component relevance is largely at the level of nucleus (GO:0005634, site of GATA4/NKX2-5/TBX5 transcriptional activity) rather than a specific organelle-level pathology (this is a morphogenetic/structural disease, not a primary organelle disease).

Localization

  • Perimembranous (adjacent to aortic and tricuspid valves) — most common clinically significant location.
  • Muscular (trabecular, apical, mid-muscular) — most common overall (many spontaneously close).
  • Inlet (AV canal type).
  • Outlet/infundibular/doubly committed subarterial (conal). Defects can be single or multiple ("Swiss cheese septum," typically multiple muscular defects). No inherent lateralization (the septum is a midline structure), though anterior/posterior/superior/inferior location within the septum is clinically relevant for surgical planning.

Sources: PMC6052685 anatomy of VSD

8. Temporal Development

Onset

  • Congenital — the anatomic defect is present at birth (embryogenesis complete by 8 weeks gestation).
  • Detection timing: Prenatal detection possible from ~18–24 weeks via fetal echocardiography (isolated VSDs detected in a large series between 19–24 weeks gestation, PMID/PMC references above); many small VSDs are detected postnatally on routine neonatal exam (murmur) or incidentally later in childhood/adulthood.
  • Symptom onset pattern: Large VSDs become symptomatic as pulmonary vascular resistance falls after birth, typically 4–8 weeks of age, coinciding with the physiologic drop in PVR that unmasks the full left-to-right shunt.

Progression

  • Disease course: Highly bimodal — (1) small/muscular VSDs frequently regress via spontaneous closure (see below), becoming asymptomatic/resolved; (2) moderate-large VSDs are progressive without intervention, evolving toward heart failure in infancy and, if uncorrected for years, irreversible pulmonary vascular disease (Eisenmenger syndrome, generally established by early childhood in the largest defects, though timeline is variable).
  • Progression rate: Rapid in large unrestrictive defects (heart failure within weeks-months of birth); slow/absent in small restrictive defects.
  • Course pattern: Largely stable once either spontaneously closed or surgically/percutaneously corrected; progressive if left uncorrected and hemodynamically significant.

Patterns — Spontaneous Closure (Remission)

  • ~85–90% of small isolated VSDs close spontaneously within the first year of life (StatPearls; PMID:38857582 reports resultant 1-year prevalence of ~0.5% down from a newborn prevalence as high as 3.3% with sensitive echo screening).
  • By 10 years of age, ~75% of small VSDs have closed spontaneously, with muscular defects closing more often (83%) than perimembranous defects (68% vs. 29% in one comparative series).
  • Closure predictors: smaller defect size, muscular (vs. perimembranous) morphology, younger age at diagnosis.
  • Some muscular VSDs close spontaneously in utero (6.8% of prenatally diagnosed muscular VSDs in one series), with an additional 75% closing within the first postnatal year.

Critical Periods

The embryologic window of weeks 4–8 of gestation is the critical period during which septal fusion occurs and during which teratogenic exposures (maternal diabetes, alcohol, retinoic acid, rubella) exert their effect. Postnatally, the first 1–2 years of life represent the critical window both for spontaneous closure to occur and, in large defects, for surgical intervention to prevent irreversible pulmonary vascular disease.

Sources: PMID:38857582, PMID:31208700 spontaneous closure rates, PMID:12206559 factors influencing closure, PMC4072558 prenatal muscular VSD natural history

9. Inheritance and Population

Epidemiology

  • Incidence/prevalence at birth: Classic teaching cites ~300–350 per 100,000 live births (~3–3.5 per 1000), representing ~30% of all newborn CHD. With sensitive echocardiographic screening protocols, newborn prevalence estimates rise substantially — one study found a 3.3% prevalence in unselected newborns, reflecting detection of small, often clinically silent muscular VSDs that would previously go undetected and would mostly close spontaneously.
  • 1-year prevalence: ~0.5% (following spontaneous closure of ~9/10 of newborn-detected defects) (PMID:38857582).
  • Adult prevalence: Estimated 0.3 per 1000 for simple/isolated VSD, making it (excluding bicuspid aortic valve) the most common CHD persisting into adulthood.
  • VSD represents nearly 50% of all infants presenting with a congenital cardiovascular anomaly in some series (StatPearls).

Inheritance Pattern

  • Isolated/non-syndromic VSD: predominantly multifactorial/polygenic inheritance, though family recurrence risk is elevated above general population risk (empiric recurrence risk for a subsequent sibling of an isolated CHD proband is commonly cited around 2–4%, higher with an affected parent).
  • Syndromic monogenic forms: Autosomal dominant for GATA4-, NKX2-5-, and TBX5-related familial CHD/Holt-Oram syndrome, with variable expressivity and incomplete penetrance.
  • Chromosomal forms: Trisomy 21 (usually sporadic nondisjunction; ~1% familial via Robertsonian translocation), 22q11.2 deletion (mostly de novo, ~10% inherited autosomal dominant from an affected parent).
  • Penetrance/expressivity: Incomplete penetrance and variable expressivity are well documented for GATA4/NKX2-5/TBX5 familial CHD pedigrees — some mutation carriers are unaffected or have only mild/subclinical defects, complicating genetic counseling.
  • Founder effects: Not prominently described for isolated VSD-causing variants (contrast with some other monogenic cardiac diseases); GATA4/NKX2-5/TBX5 mutations are generally private/family-specific.

Population Demographics

  • Sex ratio: No strong sex predilection reported in the classic epidemiologic literature (PMID:3840586), though some sources note a slight male predominance for perimembranous VSD specifically; AVSD (inlet-type, Down syndrome-associated) has no strong sex skew either.
  • Racial/ethnic and geographic variation: Incidence reported as broadly similar across races/regions in classic studies, though registry-based studies (e.g., Murmansk County, Russia, PMC6069126) identify region-specific risk-factor profiles; some studies suggest higher birth prevalence in Asian populations, potentially confounded by screening intensity.
  • Age distribution: By definition present from birth; clinically ascertained age distribution skews toward infancy (symptomatic large defects) and incidental discovery in childhood/adulthood (small residual defects).

Sources: wikidoc VSD epidemiology, PMID:38857582, PMID:3840586, AHA Journals Circulation VSD review

10. Diagnostics

Clinical Tests

  • Auscultation: Harsh holosystolic murmur, loudest at the left lower sternal border; intensity/duration inversely related to defect size for small restrictive VSDs.
  • Echocardiography (transthoracic, 2D/color Doppler) — the primary diagnostic modality: defines defect location/size, shunt direction/velocity (estimates RV/PA pressure via Doppler gradient), chamber size, and associated lesions (aortic cusp prolapse, other CHD).
  • ECG: LVH pattern with significant shunt; combined ventricular hypertrophy if pulmonary hypertension present.
  • Chest radiograph: Cardiomegaly and pulmonary vascular plethora with significant shunts; normal in small VSDs.
  • Cardiac catheterization: Reserved for cases needing precise Qp:Qs ratio and pulmonary vascular resistance measurement (especially pre-operative assessment for borderline/large defects, or when non-invasive imaging is discordant/inconclusive), and for device closure procedures.
  • Cardiac MRI/CT: Adjunctive for complex anatomy, RV/LV volumetrics, or when echo windows are poor (e.g., adult/post-surgical patients).
  • Biomarkers: BNP/NT-proBNP as adjuncts to assess hemodynamic significance/heart-failure status (not diagnostic of VSD itself).

Genetic Testing

  • Not routinely indicated for isolated, non-syndromic VSD without other anomalies.
  • Chromosomal microarray (CMA) and/or FISH for 22q11.2 deletion recommended when VSD is conotruncal-type (especially outlet/malalignment VSD) or accompanied by other 22q11.2DS features (immune, palatal, facial, endocrine).
  • Karyotype/trisomy 21 testing when VSD occurs with AVSD-type morphology or other Down syndrome features.
  • Gene panels for syndromic CHD (Noonan spectrum panel, CHD gene panels including GATA4/NKX2-5/TBX5) when familial recurrence, syndromic features, or multiple affected relatives are present.
  • Whole exome/genome sequencing increasingly used in research and clinical settings for CHD with extracardiac anomalies or suspected monogenic etiology, though yield for truly isolated non-syndromic VSD remains modest.

Prenatal / Screening

  • Fetal echocardiography (routine anatomy scan can detect larger VSDs; dedicated fetal echo for higher-risk pregnancies) from ~18–24 weeks gestation.
  • Standard screening includes 2D grayscale imaging plus color/Doppler flow mapping; 4D/STIC ultrasound increasingly used to improve detection.
  • Postnatal pulse oximetry screening (universal newborn CCHD screening) is designed primarily to detect critical cyanotic CHD and will often miss small acyanotic VSDs, which are typically identified by murmur on physical exam.

Clinical Criteria / Differential Diagnosis

Diagnosis is definitively established by echocardiography demonstrating the septal defect and shunt flow; differential diagnosis for the clinical murmur includes other left-to-right shunt lesions (ASD, PDA), semilunar valve stenosis (pulmonic/aortic stenosis murmurs), and innocent/functional murmurs of infancy.

Sources: PMC3903045 prenatal ultrasound/Doppler, PMID:31928261 fetal echo isolated VSD outcome, StatPearls VSD

11. Outcome / Prognosis

Survival and Mortality

  • Small, isolated VSDs (spontaneously closed or hemodynamically insignificant): Excellent prognosis, essentially normal life expectancy.
  • Surgically or percutaneously repaired moderate-large VSDs (repaired before development of pulmonary vascular disease): Excellent long-term survival, generally approaching that of the general population, though lifelong cardiology follow-up is recommended for residual lesions (shunt, arrhythmia, valve regurgitation).
  • Uncorrected large VSD progressing to Eisenmenger syndrome: Significantly reduced life expectancy; ventricular failure, hemoptysis, arrhythmia/sudden cardiac death, and pregnancy-related complications are the principal causes of death. Pulmonary thromboembolism occurs in a reported 21–29% of Eisenmenger patients as a complication. Eisenmenger physiology is generally considered an irreversible, inoperable state, marking a pivotal negative prognostic transition.
  • Pregnancy in Eisenmenger syndrome carries very high maternal mortality (one case series reported 36% maternal mortality), and is generally considered a contraindication to pregnancy.

Morbidity and Function

  • Post-repair morbidity: residual VSD/shunt, complete heart block (risk from surgical proximity to conduction tissue in perimembranous defects), tricuspid or aortic valve regurgitation (particularly outlet VSD with pre-existing cusp prolapse), arrhythmia (long-term surveillance concern), and rarely need for reintervention.
  • Unrepaired, hemodynamically significant VSD: failure to thrive, recurrent respiratory infections, exercise intolerance, and if progressing to Eisenmenger physiology, cyanosis, clubbing, erythrocytosis, and multi-organ effects of chronic hypoxemia.

Prognostic Factors

  • Defect size/type (muscular defects have better spontaneous closure/prognosis than perimembranous).
  • Timing of surgical correction relative to onset of pulmonary vascular disease (earlier correction before irreversible pulmonary vascular remodeling yields markedly better outcomes).
  • Presence of associated syndromic/chromosomal diagnosis (e.g., Down syndrome/AVSD carries additional risk of accelerated pulmonary vascular disease at lower shunt volumes than isolated VSD).
  • Development of aortic regurgitation (progressive, may require earlier surgical closure even for small defects to prevent valve damage).

Sources: StatPearls Eisenmenger Syndrome, PMC5112756 pregnancy outcomes Eisenmenger, Medscape VSD pathophysiology

12. Treatment

Pharmacotherapy (medical management, pre-/peri-operative)

  • Diuretics (e.g., furosemide) — for heart-failure symptom management in infants with significant left-to-right shunt (NCIT:C15986 Pharmacotherapy).
  • ACE inhibitors (e.g., captopril, enalapril) — afterload reduction to reduce shunt fraction and improve symptoms.
  • Digoxin — historically used for heart failure symptom control in infants, though use has declined.
  • Nutritional support/high-calorie formula — for failure to thrive due to increased metabolic demand (NCIT:C15433 Nutritional Support — a genuinely dietary/caloric-density intervention here, not a drug substitute).
  • Pulmonary vasodilator therapy (e.g., bosentan, sildenafil, prostacyclin analogs) — for established Eisenmenger physiology/pulmonary arterial hypertension, targeting symptom palliation rather than cure (NCIT:C15986 Pharmacotherapy; therapeutic_agent bindable to CHEBI, e.g. CHEBI:59784 bosentan, CHEBI:9139 sildenafil).

Surgical / Interventional

  • Surgical VSD closure (patch closure via cardiopulmonary bypass) — the historic standard of care for moderate-large, hemodynamically significant defects; typically performed in infancy for large defects with heart failure/failure to thrive, or electively in early childhood for moderate defects (NCIT:C15329 Surgical Procedure).
  • Transcatheter (percutaneous) device closure — an increasingly used alternative for selected muscular VSDs (technically difficult surgically) and for post-surgical residual defects; uses FDA-approved occluder devices delivered via catheter; considered particularly for complex/high-surgical-risk patients. Long-term outcomes for perimembranous device closure show durable results but historically carry a risk of complete heart block requiring careful patient selection.
  • Hybrid procedures (perventricular device closure without cardiopulmonary bypass, via small thoracotomy with echo guidance) — emerging technique combining surgical access with device delivery, reducing bypass-related morbidity.
  • Pulmonary artery banding — a palliative surgical procedure (historically, now less common) to reduce pulmonary overcirculation in infants deemed too high-risk for primary repair, as a bridge to later definitive closure.

Supportive / Rehabilitative

  • Routine pediatric cardiology follow-up echocardiography.
  • Physical activity guidance based on hemodynamic status (no restriction for small/repaired defects with normal pulmonary pressures; activity restriction for significant residual pulmonary hypertension).
  • Endocarditis prophylaxis per current AHA guidelines — generally recommended for unrepaired cyanotic CHD or during the first 6 months after prosthetic material repair, not for isolated small unrepaired VSD in current guidelines.

Experimental

  • Ongoing trials of newer transcatheter occluder device designs and refined perventricular hybrid techniques (searchable on ClinicalTrials.gov under "ventricular septal defect device closure").
  • Investigational pulmonary vasodilator regimens for established Eisenmenger physiology (combination therapy trials).

Treatment Strategy / Algorithm

General approach: (1) observe small, asymptomatic VSDs for spontaneous closure with serial echo; (2) medically manage symptomatic moderate-large VSDs with diuretics/afterload reduction while awaiting either spontaneous improvement or surgical timing; (3) proceed to surgical or transcatheter closure for large/unrestrictive defects causing heart failure, failure to thrive, or significant pulmonary overcirculation, generally before 6–12 months of age to prevent irreversible pulmonary vascular disease, or earlier if refractory heart failure; (4) closure also indicated for smaller defects complicated by progressive aortic regurgitation or recurrent endocarditis regardless of shunt magnitude; (5) for established Eisenmenger syndrome, closure is contraindicated (would acutely worsen RV afterload against fixed pulmonary vascular resistance) and management shifts to palliative pulmonary vasodilator therapy.

Sources: Johns Hopkins transcatheter VSD, PMC5943568 long-term device closure outcomes, AHA Circulation transcatheter device closure

13. Prevention

Primary Prevention

  • Periconceptional folic acid/multivitamin supplementation is the single most evidence-supported primary prevention strategy, with the strongest documented effect specifically for VSD and conotruncal defects among CHD subtypes (RR ~0.47–0.72 across studies cited above; Hungarian intervention data suggesting up to ~40% CHD reduction with high-dose periconceptional folic acid).
  • Optimization of maternal pregestational diabetes glycemic control prior to and during early pregnancy substantially reduces teratogenic CHD risk.
  • Avoidance of alcohol during pregnancy (no established safe threshold; abstinence recommended).
  • Rubella vaccination (MMR) prior to pregnancy to prevent congenital rubella syndrome-associated CHD.
  • Avoidance of known teratogenic medications (e.g., isotretinoin/retinoic acid) during pregnancy planning and gestation.

Secondary Prevention (Early Detection)

  • Prenatal fetal echocardiography for pregnancies at elevated risk (family history of CHD, maternal diabetes, known teratogen exposure, abnormal first-trimester screening/nuchal translucency).
  • Newborn physical examination (auscultation for murmur) as a low-cost universal secondary screening tool, supplemented by echocardiography when a murmur or other clinical sign is detected.
  • Genetic counseling and prenatal genetic testing (CMA, 22q11.2 FISH, karyotype) when VSD is identified prenatally, given the substantial rate of associated chromosomal/syndromic diagnoses, particularly for conotruncal/outlet and inlet/AVSD-type defects.

Tertiary Prevention

  • Timely surgical/transcatheter closure of hemodynamically significant VSD before irreversible pulmonary vascular disease develops is the key tertiary-prevention intervention, preventing progression to Eisenmenger syndrome.
  • Surveillance and early closure for progressive aortic regurgitation in outlet-type VSD to prevent long-term valve damage.

Genetic Counseling

Recommended for families with a monogenic (GATA4/NKX2-5/TBX5/Holt-Oram) or chromosomal (22q11.2, trisomy 21) etiology, addressing recurrence risk (elevated above baseline population risk of ~1% for a couple with one affected child with isolated CHD, substantially higher — up to 50% — for autosomal dominant monogenic forms) and reproductive options (preimplantation genetic diagnosis, prenatal diagnosis).

Sources: PMID:19952004, Obeid et al. folate/CHD review, PMC10930486 folate gene polymorphisms

14. Other Species / Natural Disease

  • Taxonomy of affected species: VSD occurs naturally in several domestic species, most notably dogs (Canis lupus familiaris, NCBITaxon:9615) and cats (Felis catus, NCBITaxon:9685), as well as reported in cattle, pigs, and horses.
  • Breed predisposition (dogs): English Bulldogs, West Highland White Terriers, and other breeds show elevated reported prevalence in veterinary cardiology literature (breed-specific data catalogued in OMIA and veterinary cardiology registries; specific VBO breed identifiers available via the Vertebrate Breed Ontology for these predisposed breeds).
  • Natural disease significance: VSD is among the more commonly diagnosed congenital cardiac defects in small-animal veterinary cardiology, typically identified via auscultation (murmur) and echocardiography in young animals, analogous to human clinical pathways; small/muscular defects in animals similarly show potential for a benign course, while large defects can progress to heart failure or (rarely reported) pulmonary hypertension analogous to Eisenmenger physiology.
  • Comparative biology: The embryologic septation process (fusion of muscular, membranous, inlet, and outlet septal components) is highly conserved across mammals, supporting the translational relevance of veterinary case series and of genetically engineered mouse models to human disease mechanism.
  • Orthologous genes: Mouse Gata4, Nkx2-5, and Tbx5 are direct orthologs of the human genes discussed above and drive essentially the same septation biology (see Model Organisms, below).
  • Zoonotic potential: None — VSD is a non-infectious congenital structural anomaly, not a transmissible condition.

Sources: general veterinary cardiology literature (OMIA); no specific PMID retrieved in this search pass — recommend a dedicated OMIA/veterinary-cardiology literature search if breed-level citations are required for KB entry.

15. Model Organisms

Genetic Mouse Models

  • Gata4 heterozygous / conditional mutants: Gata4+/-;Tbx5+/- compound heterozygous mouse embryos display decreased atrial/ventricular myocardial thickness by E11.5 (prior to septation) and, in more severe allelic combinations (e.g., Gata4^MyoDel/wt;Tbx5+/-), embryonic lethality with thin myocardium, reduced cardiomyocyte proliferation, and complete atrioventricular septal defects with a common AV valve — closely recapitulating features of human GATA4/TBX5-related septal defects (Oxford HMG 2014, academic.oup.com/hmg/article/23/19/5025).
  • Nkx2-5 heterozygous knockout mice: Develop muscular and membranous VSDs; genetic linkage mapping in this model identified modifier loci on mouse chromosomes 6, 8, and 10 that govern susceptibility/penetrance of membranous VSD, demonstrating a complex-trait (multi-locus) genetic architecture even for a single primary mutation (PMID:22534315).
  • Nkx2-5+/-;Sspn (Sarcospan) double mutants: Show higher incidence of muscular VSD than Nkx2-5+/- alone, establishing Sspn as a genetic modifier of VSD penetrance in this model (PMC5390293).
  • Gata4 missense knock-in models (e.g., G296S orthologous variant): Recapitulate human CHD-causing GATA4 mutation phenotypes in vivo, showing functional deficits in cardiac development consistent with the human familial phenotype (PMC3349729).

Model Characteristics

  • Phenotype recapitulation: Mouse transcription-factor mutant models (Gata4, Nkx2-5, Tbx5) faithfully reproduce the core structural phenotype (septal defects, myocardial thinning) and provide direct mechanistic insight into the cell-cycle/proliferation defect (via Cdk4/Cdk2 downregulation) underlying failed septal fusion.
  • Model limitations: Complete knockouts of these transcription factors are typically embryonic lethal at earlier developmental stages (reflecting broader essential roles in cardiogenesis beyond septation specifically), necessitating heterozygous or conditional/tissue-specific alleles to model the viable, human-relevant VSD phenotype; mouse models also do not fully capture the postnatal hemodynamic and pulmonary vascular disease progression (Eisenmenger physiology) that defines much of human VSD morbidity/mortality, since this is a consequence of the four-chambered postnatal circulation under sustained shunt physiology over years, poorly modeled in short-lived rodents.

Applications

These murine models are primarily used to dissect the causal molecular/cellular mechanism of septal non-fusion (transcription factor dosage, cell-cycle regulation, genetic modifier discovery) rather than to model the later clinical/hemodynamic natural history, which is better characterized through human longitudinal cohorts and registries.

Resources

  • MGI (Mouse Genome Informatics) — for Gata4, Nkx2-5, Tbx5 allele records and phenotype annotations.
  • IMPC (International Mouse Phenotyping Consortium) — systematic phenotyping data for knockout alleles of these genes.

Sources: academic.oup.com/hmg Gata4/Tbx5 disruption 2014, PMID:22534315 Nkx2-5 complex trait, PMC5390293 Nkx2-5/Sspn, PMC3349729 Gata4 in vivo functional deficits

Summary of Suggested Ontology Term Bindings for KB Curation

Category Suggested term(s)
Disease MONDO:0002070; HP:0001629 (VSD as phenotype); Orphanet ORPHA:1480; OMIM 614429
Causal genes GATA4 (hgnc:4171), NKX2-5 (hgnc:2488), TBX5 (hgnc:11602), CFC1 (hgnc:1878)
Phenotypes HP:0030148 (holosystolic murmur-adjacent), HP:0001635 (congestive heart failure), HP:0001508 (failure to thrive), HP:0002789 (tachypnea), HP:0002205 (recurrent respiratory infections), HP:0000961 (cyanosis), HP:0100759 (clubbing), HP:0002875 (exertional dyspnea)
Anatomy UBERON:0002094 (interventricular septum), UBERON:0002080 (right ventricle), UBERON:0002084 (left ventricle), UBERON:0002048 (lung), UBERON:0002137 (aortic valve)
Cell types CL:0000746 (cardiac muscle cell), CL:0000359 (pulmonary artery smooth muscle cell)
Biological process (GO) GO:0003281 (ventricular septum development), GO:0003148 (outflow tract septum morphogenesis), GO:0003203 (endocardial cushion morphogenesis)
Treatments (NCIT) NCIT:C15329 (Surgical Procedure), NCIT:C15986 (Pharmacotherapy), NCIT:C15433 (Nutritional Support)
Chemicals (CHEBI) CHEBI:59784 (bosentan), CHEBI:9139 (sildenafil)
Associated syndromic entities MONDO term for 22q11.2 deletion syndrome; MONDO term for Down syndrome (trisomy 21); MONDO term for Holt-Oram syndrome

Note on data gaps: This search pass did not retrieve species/breed-specific veterinary PMIDs (Section 14) or detailed single-cell/spatial transcriptomic human VSD-tissue studies (Section 6) — both would benefit from a dedicated follow-up search (OMIA for veterinary; GEO/Human Cell Atlas for omics) before finalizing a KB entry that requires citations in those specific areas.